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Body dysmorphic disorder (BDD), a psychological disorder characterized
by an intense preoccupation with an imagined physical defect, causes extreme
distress and leads to depression, divorce, and suicide. Currently, empiricallysupported treatments include cognitive-behavioral therapy (CBT) and selective
serotonin-reuptake inhibitors, however, one important component of treatment
literature yet to be investigated is the relative efficacy of cognitive or behavior
therapy as a sole treatment. In particular, examinations of change processes
throughout the course of treatment are needed. Thus, the identification of
necessary treatment components in the CBT package and the isolation of
specific change processes could lead to a more streamlined and effective
treatment approach.
The current study utilized a multiple baseline, treatment crossover design
to investigate change processes during either behavior therapy (BT) or cognitive
therapy (CT) for BDD. Following a diagnostic assessment including a semistructured interview for BDD, six individuals diagnosed with the disorder were

invited to participate, five of whom completed the study. Participants received
eight sessions of either BT or CT, followed by the same number of sessions of
the remaining treatment. BT involved exposure with response prevention (ERP),
and required the completion of ERP exercises both at home and in session. CT

967, 1976) approach, and involved the identification
sessions followed Beck's (I
and challenging of cognitive distortions. In addition to a battery of self-report
questionnaires administered at each phase change and at follow-up, daily
recordings of compulsive behaviors, appearance-related self-statements, and
global distress were gathered, as well as weekly third party assessments of
behavior.
Visual analysis of daily recordings demonstrated improvement for three of
the five participants, with behavior therapy appearing to be most effective in
reducing daily BDD symptoms. In addition, following completion of both cognitive
and behavioral treatments, three of the five participants met criteria for clinically
significant improvement on self-report measures of BDD symptoms and
depression. Finally, investigation into the covariation of BDD-related thoughts
and behaviors revealed results for two participants. Discussion focused on
implications for behavioral and cognitive theories of symptom maintenance, as
well as on interpreting current findings within the body of BDD outcome literature
and further clinical implications.
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Chapter 1
INTRODUCTION
Body dysmorphic disorder (BDD) is a chronic, debilitating disorder
characterized by extreme preoccupation with a perceived physical
abnormality. The defect in appearance is imagined, or if a slight physical
anomaly is present, an individual's concern is grossly exaggerated
(American Psychiatric Association [APA], 1994). Clients with BDD are
intensely preoccupied with their perceived defect and spend hours each
day ruminating and worrying about it. They believe their defect to be so
disgusting that others will find them repulsive. In response to these
obsessions, individuals with BDD also spend hours in compulsive
checking or other ritualized behaviors in a futile attempt to alleviate the
discomfort caused by those ruminations (APA, 1994). These rituals are
very difficult to resist and are distressing, even though the goal of the
behavior is to reduce the discomfort elicited by the ruminations. Such
debilitating symptoms may cause extreme distress and can result in
divorce, job loss, drastic cosmetic surgery, self-mutilation, and even
suicide (Hollander, Cohen, & Simeon, 1993; Phillips, 1991; Phillips,
1996a, Phillips 2000a, Sobanski & Schmidt, 2000a).
The area of concern can include any possible body part and
complaints range from specific (e.g., crooked nose) to vague areas (e.g.,
paleness of the skin). However, some areas of concern are more
common than others. For example, individuals often worry about the

shape, size, or symmetry of facial parts (e.g., nose, teeth, chin, eyes,
mouth, cheeks, or eyebrows). In a British sample of 50 individuals
diagnosed with BDD, 86% were preoccupied with an aspect of their face
(Veale, Gournay, Dryden, Boocock, Shah et al., 1996). Other common
areas include legs, hands, genitals, feet, and shoulders (Sobanski &
Schmidt, 2000a & b). Many clients also present with imagined flaws in the
skin or complexion (e.g., scars, wrinkles, paleness or redness of the skin)
and with the hair (e.g., thinning hair, abnormally shaped hairline, or
excessive growth of body hair) (Neziroglu & Yaryura-Tobias, 1993a;
Yaryura-Tobias & Neziroglu, 1997a; Phillips, 1996a; Phillips, McElroy,
Kecks, Pope, & Hudson, 1993).
Individuals with BDD experience significant distress over their
supposed deformity and often describe their preoccupations as
"tormenting" and "torturous" (Phillips, 1991, p.1140). The obsessions are
difficult to control and sufferers usually make no attempt to resist them.
Therefore, clients spend many hours a day obsessing about their defects
to the extent that the thoughts dominate their lives (APA, 1994).
lndividuals with severe cases may not leave their homes for fear of being
seen or may leave only at night. Thus, avoidance of usual activities often
leads to extreme isolation and impairment in occupational and social
functioning.
Those who suffer with BDD characteristically perform compulsive,
ritualistic behaviors driven by their obsessions and the need to reduce

their distress. Checking the defect in a mirror and other reflective
surfaces (e.g., store windows, car bumpers) is a common behavior and
can consume many hours of the day. Special lighting or magnifying
glasses sometimes are used to better scrutinize the flaw (APA, 1994).
Others compulsively avoid mirrors by covering them up, removing them
from their homes, or only using a bathroom mirror when it is covered with
steam from the shower (Phillips, 1996a). In addition, excessive grooming
behavior is common, in which individuals excessively comb hair, pick skin,
and remove hair, or ritualistically apply makeup. BDD sufferers
concerned with symmetry of body parts may also measure the flaw
compulsively (Thorpe & Olson, 1997). These behaviors are completed
with the goal of reducing distress but they serve to increase the intensity
of the preoccupation and related anxiety and depression. The negative
affect that follows BDD rituals is contrary to the rituals of obsessivecompulsive disorder, in which sufferers gain momentary relief from the
completion of a compulsion.
Muscle dysmorphia has recently been recognized as a subtype of
BDD (Pope, Gruber, Choi, Olivardia, & Phillips, 1997). Muscle
dysmorphia is characterized by an intense preoccupation with appearing
insufficiently muscular. Objectively, individuals with muscle dysmorphia
are extremely muscular, yet, they perceive themselves to be small or
skinny. Due to their embarrassment about physical appearance, these
individuals often engage in compulsive weightlifting for hours a day, often

in secret. Sufferers often eat large amounts of food, take anabolic
steroids, and wear several layers of clothing in an attempt to appear larger
(Phillips, 1999a; Phillips, O'Sullivan, & Pope, 1997). Like those with
typical BDD, individuals with muscle dysmorphia avoid situations in which
their bodies may be seen (e.g., beaches, locker rooms, swimming pools).
In addition, they may engage in compulsive mirror-checking, reassuranceseeking, and body-camouflaging. Social, occupational, and interpersonal
functioning often is impaired due to embarrassment and time-consuming
workout regimens.
Muscle dysmorphia is found in both males and females, and is
particularly prevalent in the professional bodybuilding population (Pope et
al., 1997). However, the disorder should not be confused with normal
interest in bodybuilding, which does not cause distress or impairment in
functioning. Muscle dysmorphia has been referred to as 'reverse
anorexia', and has been considered as a form of eating disorder because
of the concern about overall body shape, abnormal eating patterns, and
excessive exercise (Pope, Katz, & Hudson, 1993). However, muscle
dysmorphia differs from anorexia nervosa in that individuals are primarily
concerned with increasing body mass, and the primary focus lies with
exercise instead of diet. At the present time, the conceptualization of
muscle dysmorphia as a subtype of BDD is thought to be the most
appropriate (Phillips, 1999a). The disorder has phenomenological
similarities to BDD and responds to exposure with response prevention
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techniques similar to those utilized in the treatment of BDD. Research on
muscle dysmorphia is extremely preliminary however, and more
investigation is needed.
Because BDD is such a debilitating disorder, research on effective
treatment remains of critical importance. Currently, the outcome literature
for BDD is sparse but is increasing in size and improving in
methodological rigor. Initial reports of treatment success consisted of
case studies and pre-post measurements of symptom severity (Marks &
Mishan, 1988; Munjack, 1978). More recent studies have exercised
greater methodological control through random assignment to groups and
comparisons to no-treatment controls (Rosen, Reiter, & Oronson, 1995;
Veale et al, 1996). However, in all but one of these outcome studies, the
treatment involves a package treatment of cognitive and behavioral
techniques. No published studies have examined the relative
effectiveness of cognitive challenging versus exposure with response
prevention. In addition, although a cognitive-behavioral theory of BDD
has been proposed, no experimental testing has been conducted.
Thus, the current body of BDD literature is lacking a test of the
etiological and maintenance theories of the disorder. Although some
information exists regarding the combined effects of cognitive and
behavior therapies, we have very little knowledge regarding the essential
components of that treatment package. In addition, there is little
information on the effect of either behavior therapy (BT) or cognitive
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therapy (CT) on changing both thoughts and behaviors related to BDD
concerns. As will be discussed, both behavioral and cognitive theories of
BDD hypothesize that successful treatment would have positive
ramifications in both cognitive and behavioral realms. Therefore, an
investigation into the processes of change during behavior and cognitive
therapies would provide information regarding the utility of each individual
treatment. To address this need, the current study examines the separate
effects of behavioral and cognitive interventions on changes in BDDrelated cognitions and behaviors. Using a multiple baseline crossover
design, behavioral and cognitive theories of symptom maintenance will be
investigated by examining the effects of exposure with response
prevention and of altering maladaptive cognitive processes.
Histow and Demographics
BDD was initially described in the literature in the late 19th/early
20th centuries (Janet, 1903, as cited in Hay, 1970; Morselli, 1891 as cited
in Hay, 1970). Morselli used the term 'dysmorphophobia' to describe a
subjective feeling of physical deformity or ugliness in normally-appearing
individuals. The term comes from the Greek word 'dysmorphia', which
means abnormal shape (Yaryura-Tobias & Neziroglu, 1997b).
Dysmorphophobia has been recategorized several times throughout the
history of the Diagnostic and Statistical Manual of Mental Disorders
(DSM). In the DSM-Ill (APA, 1980) it was categorized as 'Atypical
somatoform disorder', and divided in the DSM-Ill-R (APA, 1987) into

'Delusional disorder, somatic subtype', or 'Body dysmorphic disorder',
depending on the delusionality of the preoccupation. The DSM-IV (APA,
1994) kept this distinction, but allowed for a simultaneous diagnosis of
both BDD and delusional disorder in instances where preoccupations are
of delusional quality.
lndividuals with BDD usually are diagnosed in late adolescence or
early twenties (Phillips, 1996a; Veale et al., 1996), with males and
females being equally likely to suffer with the disorder (Phillips, 1996a).
Individuals with BDD are estimated to comprise 0.7% (Otto, Wilhelm,
Cohen, & Harlow, 2001) to 2% of the population (Hollander & Wong,
1995). However, these prevalence rates are thought to be an
underestimate as many sufferers of BDD present to dermatologists and
plastic surgeons rather than to mental health professionals. Many
individuals with BDD also go undiagnosed due to extreme
embarrassment. For example, Phillips (1991 ) reported treating a
depressed client for two years before the client disclosed BDD symptoms.
The client was so ashamed of his supposed physical defect that he
stated, "I didn't have the guts to talk about it" (Phillips, 1991, p.1147). In
addition, individuals with BDD tend to present with other disorders (e.g.,
depression, social phobia, obsessive-compulsive disorder), thereby
receiving diagnosis and treatment separate from BDD (Grant, Kim, &
Crow, 2001 ; Hollander, Neville, Frenkle, & Josephson, 1992).

Differential Diaqnosis and Comorbidity
Considering that 50 to 70% of the general population report overall
body dissatisfaction, the appearance preoccupations of BDD must be
differentiated from everyday, normal concerns about how individuals look
(Biby, 1998; Castelnuevo-Tedesco, 1992). As opposed to standard
appearance concerns, the negative thoughts about appearance
demonstrated in BDD are extremely difficult to resist and often intrude on
other thoughts and cognitive processes. The preoccupations are timeconsuming, occupying several hours a day. In addition, individuals with
BDD spend significant amounts of time in repetitive, ritualistic behaviors.
Many avoid social situations or other events in which evaluation of
appearance may occur (APA, 1994). Sufferers hold onto their distorted
beliefs in the face of disputing evidence, and they may be convinced that
their defects warrant medical attention or cosmetic surgery. The
appearance concerns of the general population do not cause the same
amount of persistent, all-encompassing distress nor significant impairment
in functioning (Castelnuevo-Tedesco, 1992). Although there is evidence
of distorted appearance-related thinking patterns in the general population
(Mable, Balance, Galgan, 1986), the difference between clinical and
nonclinical distress may lie in the distinction between body dissatisfaction
and body distortion.
The presentation of BDD symptoms also resembles that of
anorexia nervosa (AN). Currently, the diagnoses of BDD and AN are

exclusionary, in that the DSM-IV (APA, 1994) excludes a diagnosis of
BDD in the presence of abnormal eating habits. However, there are many
phenomenological similarities between the two disorders. In both BDD
and AN, individuals hold a distorted perception of their appearance.
Along with this distorted view, both disorders are characterized by intense
preoccupations with physical appearance and compulsive behaviors (e.g.,
mirror-checking in BDD; weighing in AN). Both disorders involve an
overemphasis on the importance of appearance for self-worth and
relationships. Individuals with BDD or AN characteristically avoid social
situations, certain types of clothing, and other activities that result in selfconsciousness. In addition, emphasis on beauty remedies is focal in both
disorders (Rosen & Ramirez, 1998). The presentation of body
dissatisfaction is so similar between AN and BDD that eating disorders
have been assessed using BDD measures (Rosen, Reiter, & Oronsan,
1994).
Despite the above similarities, there are many factors that separate
BDD from AN. The focus of preoccupations in AN is an intense fear of
gaining weight accompanied by a refusal to maintain a body weight over
the minimal normal weight for age and height (APA, 1994). In AN, the
overall body image is distorted, however, in BDD the appearance defect
can include any conceivable body part, and is not restricted to size or
weight. Individuals with BDD may have a severely distorted image of a
particular aspect of their appearance, yet a completely rational view of the
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rest of their body. In addition, BDD and AN differ in that people with AN
often blame themselves for their weight, believing that their size is due to
their gluttony and lack of willpower (Rosen & Ramirez, 1998). On the
other hand, those with BDD usually see their defects as inherited traits or
flaws with which they were born. In a study comparing BDD and eating
disorders (Rosen & Ramirez, 1998) both groups demonstrated equally
severe disturbances in body image that were significantly greater than the
disturbance of a control group. However, individuals with eating disorders
were more concerned with the size and shape of large body regions, and
those with BDD were preoccupied with more specific areas of their
bodies. Both clinical groups, however, reported similar low levels of selfesteem. Cororve and Gleaves (2001) suggest that the gender differential
between BDD and AN could potentially be explained by cultural factors,
with intense pressures for thinness in women versus more broad
definitions for attractiveness in men.
BDD often is associated with major depressive disorder (APA,
1994). Low self-esteem and depressive symptoms often co-occur with
appearance dissatisfaction (Grubb, Sellars, & Waligroski, 1993; Mable et
al., 1986), and the rate of co-existing depression and BDD can be as high
as 82% (Phillips & Diaz, 1997). However, it is unclear whether depression
is a result of the body dissatisfaction and isolation of BDD or if it is an
etiological factor (Biby, 1998). Yaryura-Tobias and Neziroglu (1997a)
suggest that depression develops as a secondary or reactive depression

because of the disruption in social, occupational, and interpersonal
functioning. Phillips (1999b) proposes that BDD-related depression is
heterogeneous in nature, allowing a variety of relationships between the
two disorders. In this context, depression could be either secondary to or
independent of BDD, or the disorders may both lie on an affective
spectrum of pathology (Phillips, 1999b). Because sufferers sometimes
wait for years before seeking psychological assistance, the study of
depression in individuals with BDD has been hampered.
Finally, high rates of comorbidity have been demonstrated between
BDD and personality disorders. An outcome study of 17 individuals
diagnosed with BDD revealed that the entire sample met criteria for at
least one personality disorder diagnosis, with 13 meeting criteria for four
or more (Neziroglu, McKay, Todaro, & Yaryura-Tobias, 1996). The most
common diagnoses included avoidant, borderline, obsessive-compulsive,
self-defeating, and dependent. No relationship was demonstrated
between treatment outcome and number or type of personality diagnosis.
Further investigations have shown Axis-ll disorders to be prevalent among
the BDD population. Another study of 17 participants revealed 87% to
have at least one personality disorder, with a mean of 2.53 Axis-ll
diagnoses (Cohen, Kingston, Bell, Kwon, Aronowitz, & Hollander, 2000).
In this study, personality impairment was positively related to
pharmacological treatment outcome. Another large scale study also
found that 57% of 74 participants had one or more personality disorders,
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with the most common being avoidant, dependent, obsessive-compulsive,
and paranoid (Phillips & McElroy, 2000). Because of the close
resemblance between avoidant personality disorder criteria and the social
and interpersonal avoidance integral to BDD, future research should
identify whether the avoidant behaviors used in making the Axis-ll
diagnosis are over and above those typically found in BDD.
Connections Between BDD and Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) is a psychological disorder
characterized by intrusive and unwanted thoughts, ideas, or images that
lead to an increase in anxiety followed by repetitious, intentional rituals in
order to neutralize the anxiety (APA, 1994). The obsessive-compulsive
spectrum represents a set of major disorders that manifest obsessions
and compulsions of such intensity as to be considered variants of OCD
(Yaryura-Tobias & Neziroglu, 1997a). Although the DSM-IV currently
classifies BDD as a somatoform disorder, many investigators in the field
conceptualize the disorder as part of the obsessive-compulsive (OC)
spectrum (Cororve & Gleaves, 2001 ; Hollander et al., 1993; Phillips,
2000b; Yaryura-Tobias & Neziroglu, 1997b). In fact, the connections
between OCD and BDD are of sufficient magnitude that the psychological
and pharmacological treatment of BDD has been modeled after that of
OCD.
The relation between BDD and OCD may be seen on many levels.
First, BDD is phenomenologically similar to OCD. The core symptoms of

BDD resemble those of OCD in that individuals attempt to suppress
intrusive thoughts that are anxiety-producing, persistent, recurrent, and
difficult to control (Phillips, et al., 1993). In both disorders, individuals
perform irresistible compulsions in response to discomfort elicited by the
obsessions. For example, an OCD sufferer may experience an obsession
about the harmful nature of germs and respond by repeated and ritualistic
washing. With BDD, the thought that a pimple causes the person to
appear disgustingly ugly could lead to ritualistic mirror-checking and skinpicking in an attempt to reduce distress and improve the appearance of
the face. In addition, similarities exist in general obsessional content and
structure of rituals. For instance, preoccupations in both disorders often
center around a need for symmetry, perfection, and the sense of being
"just right", whereas compulsions common to both include checking and
reassurance-seeking (Phillips, 2000b). In fact, symptomatology appears
so similar that BDD is often misdiagnosed as OCD (Vitello & deleon,
1990).
Obviously, however, phenomenological differences also exist. The
specific content of BDD-related obsessions focuses on appearance,
whereas those of OCD center around other concerns. In addition, BDD
preoccupations are associated more often with shame, fear of rejection,
and low self-esteem (Phillips, 2000b), and BDD-related rituals tend to
increase rather than decrease distress (Neziroglu, 2000). In addition,
BDD rituals have a somewhat reasonable connection to the content of the
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preoccupations. For example, the thought that a body part is ugly may
lead to the examining of that feature in the mirror. In OCD, the content of
the obsessions often has no logical transition to the coinciding
compulsions (e.g., counting to 100 in multiples of three in an attempt to
prevent harm). Finally, level of insight in BDD tends to be more
compromised, in that delusions of reference and beliefs of delusional or
overvalued intensity occur more often than with OCD (Phillips, 2000b;
Simeon, Hollander, Stein, Cohen, & Aronowitz, 1995).
Both BDD and OCD have similar demographic characteristics, age
of onset, and course of symptomatology. In a comparison study, the two
groups were similar on education level, and gender ratio was found to be
approximately 1:l for both disorders (Phillips, Gunderson, Mallay,
McElroy, & Carter, 1998). In addition, the onset of both disorders often is
seen in childhood or early adolescence and, when untreated, typically
progresses with a chronic course. However, those who suffered with BDD
were significantly less likely to have been married (Phillips, 2000a).
BDD and OCD also are highly comorbid with each other and with
other similar disorders. In a study of 100 BDD clients, 34% also met
criteria for OCD (Phillips, McElroy, Keck, Hudson, & Pope, 1994), and
studies of OCD find comorbidity rates of up to 37% for BDD (Hollander et
al., 1993; Phillips et al., 1998; Simeon, et al., 1995). Both disorders
generally have similar comorbidity patterns with other disorders, however,
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individuals with BDD have significantly higher rates of major depression
and social phobia (Phillips et al., 1998).
Finally, results of pharmacological studies suggest a relationship
between BDD and OCD in the preferential responses to selective
serotonin reuptake inhibitors (SSRls; Phillips, Albertini, Siniscalchi, Khan,
Robinson, 2001). The possibility of common neurochemical mechanisms
has been suggested due to the fact that individuals with BDD or OCD who
are unresponsive to cognitive-behavioral treatment respond positively to
the same selective serotonin-reuptake inhibitors (Hollander, Leibowitz,
Winchel, Klumker, & Klein, 1989; Hollander et al., 1993). In addition,
pharmacological augmentation strategies used for OCD nonresponders
also have been useful in treating refractory BDD (Phillips, 1996~).
Although these similarities do not represent definitive evidence, the
conceptualization of BDD as an OC-spectrum disorder is reasonable.
Thus, the behavioral theory and treatment of BDD has developed from the
behavioral model of OCD.
Behavioral Theory of OCD
The behavioral conceptualization of OCD is based upon Mowrer's
two-factor learning theory (Mowrer, 1960), which explains the acquisition
of general fear and avoidance through the principles of classical and
operant conditioning. The first stage of this theory (acquisition) postulates
that fear is acquired through the process of classical conditioning, which
focuses on the association between a neutral stimulus and a reflexive
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fearful response. According to conditioning theory, an aversive stimulus
that automatically precedes an aversive response becomes paired with a
neutral stimulus. Through this pairing, the neutral stimulus acquires the
ability to elicit that aversive response. These conditioned stimuli may
include concrete objects, as well as thoughts and images. The second
stage (fear maintenance) operates on the reinforcement principles of
operant conditioning, specifically those of negative reinforcement. With
negative reinforcement, behaviors are maintained or increased through
the blocking or avoidance of an aversive stimulus. In OCD, rituals and
avoidance behaviors are developed and maintained through negative
reinforcement because they reduce anxiety evoked by the conditioned
stimulus in stage one (Mowrer, 1960).
The first fear-acquisition stage of Mowrer's two-factor theory (1960)
is not thought to be an adequate explanation for the initial development of
obsessive fears (Foa & Tillmanns, 1980; Rachman & Shafran, 1998;
Steketee & Tynes, 1991). During this phase, a previously neutral stimulus
becomes paired with a stimulus that naturally produces fear, and the
neutral stimulus then acquires the ability to elicit the fearful response.
However, many OCD sufferers cannot recall aversive learning events that
are related thematically to the obsessions or compulsions nor with the
onset of symptoms (Rachman, & Shafran, 1998; Steketee & Tynes,
1991).

17

Despite a lack of ability to account for the acquisition of obsessive
fears, Mowrer's model has been utilized as an explanation of symptom
maintenance. The application of Mowrer's theory to the behavioral model
of OCD focuses mainly on the second stage of fear maintenance, which
adheres to reinforcement principles as an explanation for the
maintenance of compulsive rituals and avoidance behaviors. In both
subjective and physiological domains, empirical support for the anxietyreducing properties of compulsions has been demonstrated (Rachman &
Hodgson, 1980; Rachman, & Shafran, 1998). Thus, OCD has been
conceptualized in terms of a functional relationship between obsessivecompulsive symptoms and anxiety (Foa & Tillmanns, 1980). In other
words, obsessive thoughts, images, and impulses elicit anxiety, and
compulsive behaviors are seen as attempts to decrease that anxiety.
Thus, compulsive rituals are maintained by their negatively reinforcing
properties, and are performed repeatedly until discomfort has decreased.
When exposed to a fearful obsession, individuals repeatedly perform
rituals that artificially and temporarily reduce the discomfort and prevent
the natural habituation to that stimulus. It is this prevention of the natural
habituation process that is the target of the currently empirically supported
behavioral treatment for OCD - exposure with response prevention (ERP).
ERP involves the repeated exposure to obsessional material and
the prevention of the ritualized behaviors, in order to disrupt the negatively
reinforcing properties of the ritual and to allow for extinction of the anxiety

response (Meyer, 1966). As previously mentioned, rituals are
conceptualized as a maintaining factor because they prevent the natural
habituation to discomfort by reducing the distress more rapidly, albeit
temporarily. Consequently, individuals do not experience the naturallyoccurring, yet slower, decrease in anxiety that would take place in the
absence of the ritual. Thus, during ERP, individuals are exposed to the
anxiety-provoking stimulus so that the ritual prevention component can
allow for the extinction of the anxiety response.
Behavioral Theow of BDD.
Because BDD has been conceptualized as an OC-spectrum
disorder, Mowrer's two-factor theory may be an appropriate model on
which to base a behavioral theory of BDD. Indeed, early learning
experiences have been discussed as precursors in the development of
BDD symptoms (Rosen et al., 1995). For example, in keeping with the
classical conditioning model for fear acquisition, humiliating teasing and
peer rejection may naturally create an anxiety response. Then, events
involving appearance evaluation become paired with anxiety-provoking
teasing so that appearance-related thoughts and situations acquire the
ability to create an anxiety response.
As possible support for this theory, BDD symptoms often are
reported to first appear in adolescence, a time during which physical
differences are especially powerful elicitors of peer attention (Phillips,
1991; Phillips, Atala, & Albertini, 1995; Neziroglu & Yaryura-Tobias,
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1993a). In addition, Phillips (1996b) reported several examples in which
the development of BDD symptoms coincided with negative comments
about appearance. For example, one client began worrying about his
appearance when high school friends called him "pizza face" (Phillips,
1996b, p.186). Following this comment, the client felt extremely selfconscious about his skin and began checking his face in the mirror
several times a day. In another study (O'Grady, Thorpe, & Hecker, 1999),
a client was able to pinpoint a humiliating experience in late adolescence
that marked the beginning of obsessions about her feet. Yet another BDD
sufferer recalled painful teasing about facial ugliness that he associated
with the onset of BDD symptoms and several suicide attempts (O'Grady,
Hecker, Thorpe, & Maki, 2001). Thus, for some individuals, negative
appearance-related learning experiences appear to precede the onset of
BDD symptoms.
However, Mowrer's fear acquisition theory currently lacks empirical
support as an explanation for BDD symptom onset. Research has not
demonstrated such conditioning events in all BDD sufferers, nor does
BDD develop in every individual who has been teased about appearance.
Therefore, at this point in time, classical conditioning events may be seen
only as a contributing factor to the development of BDD.
The second component of Mowrer's two-factor theory (fear
maintenance) may be used to explain the maintenance of BDD rituals and
avoidance behaviors. Through negative reinforcement, the avoidance

behaviors are strengthened and the association between the feared
stimuli and aversive events is maintained. Escape and avoidance
behaviors prevent the natural habituation to discomfort and, therefore, are
maintained as the typical fear response (Hodgson & Rachman, 1972;
Roper, Rachman, & Hodgson, 1973). In the case of BDD, avoidance of
and escape from social situations are negatively reinforcing because the
discomfort, embarrassment, and humiliation of exposing the defect is
avoided or reduced.
Also hypothesized to be reinforcing, rituals such as mirror-checking
and reassurance-seeking are thought to provide short-term relief
(Yaryura-Tobias & Neziroglu, 1997a). Paradoxically, however, individuals
report an increase in distress both during and after the ritual (Phillips,
1996b; Veale & Riley, 2001). One explanation for this conflict may be that
individuals experience a very short period of relief that is reinforcing, only
to be followed by intense feelings of ugliness, guilt, and shame for
conducting the ritual. The fleeting relief that follows the ritual may be
sufficiently reinforcing to maintain the behavior. Rituals also may be
maintained because the discomfort of not performing the ritual would
increase to levels even higher than those experienced during ritual.
Clients have reported strong beliefs and images of ugliness that mount in
intensity prior to mirror-checking rituals (O'Grady, Thorpe, & Hecker,
1999). Such reports revealed that the image seen in the mirror is
perceived as terribly ugly, but not quite as horrendous as the imagined
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appearance. Thus, although mirror-checking may provide some level of
reinforcing reassurance, the negative feelings associated with the
perceived ugliness of the reflection still are intense and distressing. Thus,
rituals such as mirror-checking and reassurance-seeking create a vicious
cycle in which attending to anxiety-provoking body parts is both
reinforcing, yet disturbing.
One study of mirror-checking compared 52 BDD clients with 55
controls using a self-report mirror-gazing questionnaire (Veale & Riley,
2001). Results demonstrated that, prior to checking the mirror, BDD
clients reported several motivations: the hope that they would look
different this time, the urge to know exactly how they appeared, the belief
that they would feel worse if they did not check, and the intention to
camouflage. BDD clients were more likely than controls to focus on an
internal feeling rather than specific body parts, to practice a face that they
would present while in public, and to use "mental cosmetic surgery" to
change their body image. In addition, those with BDD reported feeling
worse following the period of mirror-checking.
As with OCD treatment, ERP exercises conducted in the treatment
of BDD encourage exposure to anxiety-provoking situations (e.g.,
attending social and public events, exposing the defect to another person)
and prevention from ritualizing (e.g., dashing from the party, covering the
defect). The intent of ERP is to allow for the natural habituation to the
situation and, ultimately, the extinction of the anxiety response.

Beck's Cognitive Theory
The cognitive model of BDD follows from Beck's conceptualization
of depression (Beck, 1963; 1964;1976a), which also has been applied as
a model for anxiety disorders (Beck, Emery, & Greenberg, 1985). Within
this model, distorted information processing strategies and dysfunctional
assumptions about the self, world, and others arise from maladaptive
cognitive schemas. Thus, cognitive therapy strives to alter unhelpful
schemas by challenging faulty assumptions and replacing distorted
cognitive processes with more adaptive strategies. In addition,
therapeutic cognitive change is thought to produce consequent
modifications in both behavior and affect. Thus, although thoughts are
the direct target of cognitive therapy, treatment is believed to have positive
ramifications on emotions and actions.
Beck's cognitive model is composed of three concepts: the
cognitive triad, schemas, and cognitive distortions. The cognitive triad
represents an idiosyncratic pattern of thought encompassing the self, the
world, and the future. Negative views of the self lead to unpleasant
experiences, which are thought to be further evidence of personal defects.
Then, individuals draw illogical connections between their supposed
personal flaws and their ultimate character, which may be assumed to be
worthless and unlovable. In addition, the individual's ongoing experiences
and the world in general are interpreted as negative. The world is seen as
making excessive demands, placing unreasonable obstacles throughout
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daily life. Ongoing interactions with the environment often are negatively
misconstrued, despite more obvious and positive interpretations. The
final aspect of the cognitive triad involves a pessimistic view of the future.
Long-term expectations of life include the continuation of current
difficulties and the introduction of additional frustrations, hardships, and
unfair consequences.
The second component of Beck's cognitive model (Beck, 1963;
1964; 1976) is the concept of schemas. Schemas are hypothesized
frameworks that influence the organization of incoming information and
guide the understanding of life experience (Freeman & Davis, 1990). Any
given situation may be perceived in multiple ways due to the variety of
available information. According to cognitive theory, any one individual
will attend selectively to particular stimuli and organize the information
according to their own internal framework or schema. The schema is a
relatively stable structure that allows for consistent responses to similar
situations, with different schemas hypothesized to be activated in different
situations. When the situational-specific schema is activated, it guides the
processing of the event such that environmental stimuli are categorized
and evaluated in agreement with the schema. An individual then
responds in a manner congruent with the interpretation. Some schemas
may be dormant for a period of time and then activated by a specific
stressful event. Because information is organized to be consonant with
the activated schema, a dysfunctional schema elicited by a stressful event
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would organize information in a pathological manner, so that an individual
selectively attends to negative stimuli. Thus, situations will be
misinterpreted and information organized in an inappropriate manner and
with negative content.
The final component of Beck's model incorporates faulty methods
of information processing, referred to as cognitive distortions. Cognitive
distortions are routine errors in thinking that are based on idiosyncratic
views (Beck 1967, Freeman & ~avis,'1990). The distortions, which are
consonant with activated schemas, serve to support an individual's
negative beliefs even in the presence of contradictory information. For
example, the distortion referred to as 'selective abstraction' involves
conceptualizing an entire experience based on a seemingly minor and
inconsequential detail, while ignoring more salient and pertinent
information. Another pattern (dichotomous thinking) describes a tendency
to place all experiences in one of two polarized categories. Thus, through
the faulty processing and organization of information, cognitive distortions
are the mechanism through which negative schemas are supported and
maintained.
Beck's cognitive therapy follows directly from the above theory.
According to cognitive theory, the content of underlying schemas is
reflected in the theme of these cognitive distortions. Therefore, distortions
become the initial target of treatment as a means of ultimately accessing
and altering the unhelpful schema. Distortions, in turn, can be accessed
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through automatic thoughts, which are spontaneous thoughts associated
with certain situations and mood states (Beck, 1995; Freeman & Davis,
1990). Therapy involves tracking these spontaneous and automatic
statements across situations in order to identify the distortions. The
labeling of distortions allows an individual to understand dysfunctional
thought patterns and begin to alter them. The ultimate goal of altering
these patterns is to challenge the underlying maladaptive schema and
initiate the development of one that is more adaptive.
Cognitive theory proposes that the most strategic method for
creating therapeutic change is through altering inner beliefs and thinking
patterns. Due to the idiosyncratic nature of cognitive processes, each
individual will perceive, and therefore react, differently in a given situation.
Thus, the perception of an event, not the event itself, determines the
consequent emotional reaction. Therefore, according to cognitive theory,
the most beneficial point of intervention lies with cognitions. Because
cognitions are believed to be linked with both behavior and affect, a
change in one component is hypothesized to result in change among the
others (Beck, 1976; 1996, Freeman & Davis, 1990). Successful cognitive
therapy should result not only in positive cognitive change, but in
beneficial modifications in behavior and emotion as well.
Cognitive Theory of BDD
The cognitive approach to BDD incorporates Beck's concepts of
schemas, cognitive distortions, and automatic thoughts. As discussed

previously, Beck's cognitive theory (1964, 1976) proposes that an
individual's perception of events is dictated by an underlying schema, the
content of which shapes the attitudes and beliefs that influence thought,
behavior, and affect. According to Beck's theory, schemas develop early
in life due to learning experiences, and lie dormant until activated by a
relevant event. Once the schema is activated, perceptions are colored by
the content of that schema. Thus, an individual with a particular schema
will process relevant information differently than someone without a
similar structure and, therefore, emotion and behavior will be influenced
by the perception of an event rather than the event itself.
The concept of schemas may be applied to the development of
BDD. Negative appearance-related experiences have been hypothesized
to set the stage for distorted assumptions about the normality of
appearance and for dysfunctional connections between appearance, selfworth and acceptance (Rosen et al., 1995). These experiences could be
conceptualized as precipitating factors in the development of a
maladaptive schema. Once developed, the schema would influence the
perception of appearance-related situations. According to Cash and
Labarge (1996). 'appearance-schematic' individuals react to and process
appearance-related stimuli differently than those who are 'aschematic'.
Individuals schematic for appearance are more invested psychologically in
their physical presentation because appearance is considered to be an
index of self-worth and a standard for evaluation. Individuals with BDD

may have these negative appearance schemas and interpret events
based on the belief 'I am ugly.' This belief causes an individual to
respond negatively to beauty-related stimuli, shapes the interpretation of
appearance-related situations, and influences consequent emotions and
behaviors (Cash & Labarge, 1996).
One difficulty with this theory is the inability to explain why some
individuals develop BDD and others with similar early learning
experiences (e.g., childhood teasing) do not develop the disorder.
Perhaps, for some reason, these individuals do not develop maladaptive
appearance schemas at all despite humiliating childhood experiences.
Perhaps the maladaptive schema does develop but future buffering
experiences keep the distress at a subthreshold level. Another possibility
is that the schema develops but continues to lie dormant. These
questions remain unanswered.
In addition to the influence of schemas, other cognitive experiences
(e.g., cognitive distortions, negative self-statements) are thought to
maintain BDD symptoms (Geremia, 1997; Rosen, 1995). As discussed
previously, cognitive distortions are negative thought patterns that arise
from negative schemas. The distortion is thought to reflect the thematic
content of the schema. For instance, an 'ugly appearance' schema would
give rise to cognitive distortions about physical attractiveness. One such
distortion commonly seen in BDD is referred to as 'all-or-none thinking'
and involves categorizing experiences in terms of extreme categories
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(Geremia, 1997). An example of all-or-none thinking in BDD is the belief 'I
have a pimple, therefore my whole appearance is ruined', or 'if I am not
physically perfect then I must be ugly.' Another cognitive distortion
commonly found in BDD is 'disqualifying the positive' in which positive
experiences are discounted so as not to contradict the negative belief
(Geremia, 1997). This distortion occurs regularly during repetitive
reassurance-seeking, during which positive comments about appearance
are dismissed as sympathetic expressions elicited by the clients' extreme
ugliness.
BDD symptoms also may be perpetuated through the rehearsal of
negative self-statements (Rosen et al., 1995). Statements such as "I am
ugly and worthless" may be rehearsed to the extent that they become
believable and automatic. In keeping with Beck's theory, these automatic
thoughts may be seen as reflections of a maladaptive schema. Thus,
disconfirming evidence for these statements may be discounted due to
distorted thinking patterns.
As discussed earlier, cognitive theory proposes that the most
effective point of intervention lies with changing accessible thinking
patterns, with the ultimate goal being to alter the underlying schema.
Because of the proposed connection among thoughts, emotions, and
behaviors, altering thinking patterns is believed to result in therapeutic
changes in all three realms. Therefore, initial goals of cognitive therapy
for BDD would include identifying and challenging appearance-related

cognitive distortions through the monitoring of automatic thoughts.
Therapeutic work at this level would move toward challenging and altering
maladaptive inner beliefs about the self and connections between
appearance and worth. As therapeutic cognitive gains were made,
positive changes in affect and behavior also would be expected.
Empirical Support for ERP and CT with OCD
Because BDD is considered to be within the OC-spectrum, results
of the behavioral and cognitive treatments for OCD could be useful, as
they may extrapolate to the treatment of BDD. Therefore, the following
section discusses the empirical evidence for ERP and CT as applied in
the treatment of OCD.
Meyer (1966) was the first to implement ERP as a treatment for
OCD and, since then, it has become the first-line psychological treatment
(Marks, 1997; Steketee & Tynes, 1991). The efficacy of ERP in reducing
OCD symptoms has been demonstrated in pre- and post-treatment
studies (Boersma, Den Hengst, Dekker, & Emmelkamp, 1976;
Emmelkamp & Kraanen, 1977; Foa & Goldstein, 1978; Foa, Grayson,
Steketee, Doppelt, Turner, & Latimer, 1983), and in comparison to a
relaxation-training control (Rachman, Marks, & Hodgson, 1973; Roper,
Rachman, & Marks, 1975). Foa and colleagues summarized 20 studies of
ERP treatment for OCD (Foa, Steketee, & Ozarow, 1985). They observed
that following ERP, 51% of individuals were either 'symptom free' or
'much improved', whereas another 39% were 'moderately improved.'
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Only 10% demonstrated no change. In addition, two reviews of controlled
studies concluded that OCD symptoms improved more with ERP than with
SSRls, and that improvements were maintained for years following ERP
compared to relapse after pharmacotherapy (Abel, 1993; van Balkom, van
Oppen, Vermeulen, van Dyck, Nauta, & Vorst, 1994). The efficacy of
ERP has been demonstrated, not only at post-treatment, but also in
follow-up investigations ranging in time from one to six years following
treatment (O'Sullivan & Marks, 1990).
In addition to reducing behavioral rituals, ERP has been
demonstrated to reduce the frequency of obsessions, as well as the
distress associated with the obsessions. In one study of 21 participants
treated with ERP, 12 reported no obsessive symptoms following
treatment, whereas eight reported mild to moderate obsessions, and one
remained unchanged (Foa & Goldstein, 1978). Other more recent studies
also have shown a decrease in obsessions and associated anxiety
following ERP. For example, one investigation of 46 participants
demonstrated that reduction in fixity of beliefs (i.e., strength of belief in
feared consequence as a result of not ritualizing) and increase in
resistance to obsessions correlated significantly with reductions in
compulsions (Ito, Araujo, Hemsley, & Marks, 1995). Although obsessions
did decrease following behavioral treatment, improvement was greater on
behavioral measures (e.g., frequency of rituals and avoidance behaviors).
Another study of 41 participants examined the effect of ERP on three
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measures of cognitive change: (i) strength of belief that consequence of
not ritualizing will occur, (ii) recognition of absurdity of obsession, and (iii)
degree of conviction in the face of contradictory evidence (Lelliot,
Noshirvani, Basoglu, Marks, & Monteiro, 1988). Results indicated that
decreases in scores on the three cognitive scales correlated significantly
with decreases in ritual frequency.
Initial studies of cognitive therapy (CT) alone have provided
positive results. The first randomized controlled trial of CT for OCD
compared rational emotive therapy (RET) with ERP (Emmelkamp, Visser
& Hoekstra, 1988). A total of 18 participants received 10 sessions of

either treatment. At post-treatment and at a six-month follow up, both
treatments resulted in significant decreases in obsessive-compulsive
symptoms, with no significant differences between the efficacy of the two
therapies. In addition, CT significantly improved depressed affect, but
ERP did not. Another study compared ERP to the combined effects of
ERP and CT (Emmelkamp & Beens, 1991). Post-treatment comparisons
of ERP and RET demonstrated no significant differences on symptom
improvement. However, adding ERP to RET provided no incremental
benefit.
Van Oppen and colleagues conducted the first randomized
controlled trial evaluating Beck's model of CT for OCD (van Oppen, de
Haan, van Balkom, Spinhoven, Hoogduin et al., 1995). In this study, 71
participants were randomly assigned to 16 sessions of either CT or ERP.

32

Overall, results demonstrated that both treatments significantly improved
OCD symptoms to a similar degree. However, CT showed superior
efficacy on some measures of OC symptoms and on generalized
measures of psychological distress. Results supporting the efficacy of
ERP and CT were discussed in a recent review (Abromowitz, 1997). The
meta-analysis utilized only studies with direct comparisons of randomly
assigned groups, and examined comparisons between ERP and
relaxation training, as well as those between ERP and CT. Although
effect sizes demonstrated a clear superiority of ERP over relaxation
training, no significant difference between ERP and CT was found.
Most recently, Salkovskis' (1996) model has been utilized in the
comparison of cognitive and cognitive-behavioral group therapies for OCD
(McLean, Whittal, Thordarson, Taylor, Sochting, Koch, et al., 2001). This study
of 76 participants compared a CT group and a CBT group to a waitlist control,
demonstrating that both treatments were superior to the control group on a
measure of obsessive-compulsive symptoms. In addition, ERP alone was
marginally more effective at post-treatment than the combined CBT intervention,
with ERP demonstrating a significantly superior effect at a three-month follow-up.
Interestingly, only one of seven cognitive measures improved over treatment for
both the ERP and CBT groups.
Despite the above findings supporting the efficacy of CT for OCD, some
investigators propose that evidence is insufficient to draw firm conclusions
(James & Blackburn, 1995; Stanley & Averill, 1998). Following a review of
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available studies, James and Blackburn (1995) state that although preliminary
results may lead to optimistic conclusions, such judgments are premature. First,
various forms of CT have been utilized, including Beck's model, Salkovski's
model, and RET. Therefore, generalized conclusions regarding the efficacy of
CT cannot be drawn. In addition, some studies incorporate behavioral
experiments that involve some exposure procedures. Therefore, by adding
behavioral components to CT, a test of pure cognitive strategies is precluded
(James & Blackburn, 1995; Stanley & Averill, 1998). Thus, although initial
results are promising, the current supporting body of literature may best be
considered preliminary.
Additional Theories of BDD
Evolutionarv significance. The theory of evolutionary significance
discusses the potentially adaptive nature of typical BDD concerns.
According to the theory, two biological factors are hypothesized to
contribute to the development of BDD. First, many individuals with BDD
are concerned with the perfect symmetry of body parts, such as ears,
eyes, breasts, and legs (Phillips, l996a). Veale and colleagues (1996)
hypothesize that this drive for symmetry is innate because symmetrical
body parts are indicative of biological quality. Thus, biological symmetry
attracts sexual partners by advertising resistance to developmental
disruptions. Second, the authors propose that the fear of rejection salient
in BDD sufferers is an adaptive, innate response as well. Those who are
rejected by potential mates are less likely to procreate. Therefore, the
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innate drive to pass on genetic material may foster a fear of rejection as
an adaptive mechanism.
Veale and colleagues (1996) link this evolutionary theory to the
cognitive theory discussed earlier. Because an increased drive for
symmetry and fear of rejection are proposed to have evolutionary
significance, thoughts and behaviors that are consonant with such
predispositions may be considered adaptive as well. Individuals who are
strongly predisposed to these factors may be more responsive to cues of
symmetry or rejection and may develop schemata that increase the risk
for developing BDD. However, Veale and colleagues do not explain how
the schemata would develop. Another problem with the theory is that
there is no viable method of supporting or disconfirming the presence of
such biological predispositions, other than the presence of the symptoms
themselves. It could be hypothesized that BDD-related cognitions and
behaviors are due to certain innate factors gone awry, but there must be a
way of testing those suppositions before the theory can be supported. At
this time, the capability of assessing and measuring biological
predispositions does not exist. Thus, the circular argument remains in
which predispositions exist because symptoms are present; and the
symptoms are present due to the predispositions.
An additional difficulty with this theory is the failure to propose
causal factors for such extreme development of the predispositions.
Evolutionary theory focuses on the adaptive significance of hereditary
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traits and the extinction of maladaptive characteristics. Although a drive
for symmetrical body parts and a fear of rejection may be beneficial in
moderation, the preoccupation demonstrated in BDD is disabling in
intensity. The theory does not propose how adaptive concern about
physical presentation could develop into pathological obsessions over
imagined defects.
Selective attention. According to Veale and colleagues (1996),
another maintaining factor is the selective attention of BDD clients to their
perceived defect. This selective attention results in a heightened
perception and overly-accurate representation of the flawed feature which,
in turn, may result in a negative judgment of appearance (Veale et al.,
1996). Jerome (1992) presents observations consistent with the idea that
BDD clients selectively overfocus on their imagined defects. Twenty
cosmetic rhinoplasty patients who met criteria for BDD demonstrated a
more accurate estimation of nose size than controls. Following surgery,
however, BDD clients failed to maintain their previous level of accuracy,
and nose size estimation fell within range of controls. Jerome proposes
that constant mirror-checking and overfocusing on nose shape and
dimensions form the basis of their overly accurate estimations of nose
size. After surgery, heavy bandaging prevents such selective attention
and results in a more normal estimation. According to Jerome, the
prevention of such focusing, often achieved by mirror-checking, may
reduce BDD symptoms.
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A recent study investigated selective attention and overfocusing in
BDD sufferers (Deckersbach, Savage, Wilhelm, Buhlmann, Reid, et al.,
1998). This study examined whether clients tended to focus on specific
details of visual material or to integrate those details into a more global
picture. BDD clients and matched controls were administered the ReyOsterrieth Complex Figure Test (CFT; Austerity, 1944 as cited in
Deckersbach et al., 1998), a commonly-used neuropsychological
measure. The CFT requires the examinee to copy a complex geometric
figure, and then to draw it from memory. Scores on the CTF provide
information on the accuracy of copied or recalled elements, and quantifies
the organization of the figure (i.e., how much participants focused on the
details while copying the figure). Focusing on details of the figure rather
than the global picture interferes with reproduction of the figures.
Interestingly, the performance of individuals with BDD on both the copy
and recall conditions was significantly impaired compared to controls,
suggesting a focus on particular details rather than on the global figure.
Although the BDD group copied the CTF figure as accurately as controls,
they obtained lower organization scores (i-e., the copied version was
accurate and complete but the process of construction was disorganized).
In addition, BDD clients remembered significantly fewer components of
the design when asked to produce the figure from memory. Therefore,
Deckersbach and colleagues concluded that individuals with BDD
encoded an unstructured, piece-by-piece, distorted representation of the

37

CFT into memory, which unlike a structured representation, was difficult to
reproduce from memory. The authors interpreted these results as
indicative of selective attention.
The phenomenon of attentional bias in BDD is intriguing, however,
current data are based on a small number of individuals. Further
investigation could utilize more precise measurements of attentional bias
to address questions concerning individual differences, and the causes
and consequence of selective attention.
Psvchodvnamic theorv. According to psychodynamic theory, BDD
results from the unconscious displacement of sexual or emotional conflict
(Bloch & Glue, 1988). Preoccupation with the appearance defect,
therefore, acts as a disguise for the true source of distress. Within the
psychodynamic interpretation, the body part of concern takes on symbolic
meaning (Phillippopoulos, 1979). For example, the nose is considered as
a phallic symbol. Thus, a woman who requests rhinoplasty is interpreted
as attempting to relieve a conflicted identification with her father in order
to progress into a more feminine role. However, a man who requests a
smaller nose is considered to be experiencing latent homosexuality. No
empirical evidence exists to support the psychodynamic conceptualization
of BDD.
Treatment of BDD
Currently, cognitive-behavioral therapy (CBT) and
pharmacotherapy with serotonin-reuptake inhibitors are the only
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treatments for BDD that are empirically supported (Chambless & Hollon,
1998). Psychodynamic treatments have been documented as well (Bloch
& Glue, 1988; Philippopoulos, 1979) but reports of success are subjective

in nature. In addition, one report of eye movement desensitization and
reprocessing demonstrated a reduction in BDD symptoms (Brown,
McGoldrich, & Buchanan, 1997). Although CBT is considered to be one
of the two empirically supported treatments, the study of CBT for BDD is
in its early stages. There exist only a handful of CBT outcome studies,
most of which are uncontrolled. In many cases, measures of treatment
effectiveness are restricted to pre- and post-treatment comparisons.
In an early case study of a 27-year-old male, the effectiveness of
behavioral therapy for BDD was reported (Munjack, 1978). Treatment
consisted of 11 sessions of systematic desensitization to address an
intense preoccupation with facial redness. Following relaxation training,
two hierarchies were constructed using fears of scrutiny and verbal
criticism. During each session, relaxation therapy was followed by
imaginal exposure of hierarchy items. At post-treatment, the client
reported being no longer bothered by preoccupations about his red
complexion. Another early report of behavior therapy discusses the
inpatient treatment of five individuals who suffered chronically with BDD
(Marks & Mishan, 1988). These five case reports outline the behavioral
treatment, which consisted primarily of exposure and response
prevention. Clients demonstrated a decrease in avoidance behaviors and

associated anxiety. In addition, the delusional beliefs, previously
assessed as "unamenable" (p.678). were reported as having weakened or
disappeared. No cognitive therapy or challenging of those beliefs had
been conducted. Unfortunately, three of the five clients also had begun
pharmacotherapy during behavioral treatment; therefore, results cannot
be attributed solely to psychotherapy.
More recently, Neziroglu and Yaryura-Tobias (1993b) report the
use of CBT with five BDD clients. Intensive treatment consisted of four
weeks of 90-minute sessions, five days a week. The first 60 minutes of
each session were spent on exposure with response prevention (ERP).
Cognitive therapy, involving identification and challenging of irrational
cognitions, was conducted during the remainder of the session. Clients
were assessed pre- and post- treatment, and at a one-year follow-up
using the Overvalued Ideation Scale (OW) and the Yale Brown Obsessive
Compulsive Scale adapted for BDD (YBOCS-BDD). Following CBT,
clients obtained lower scores on both measures, indicating reductions in
levels of obsessions and behavior. One drawback, however, is that both
measures of distress relied on self-report and, therefore, are open to
subjective interpretation.
In another study, Neziroglu and colleagues examined the effect of
CBT and the presence of comorbid personality disorders in 17 participants
with BDD (Neziroglu, et a]., 1996). As in the above study, treatment
consisted of daily 90-minute sessions over a four-week period. A

combination of ERP and challenging of cognitions was implemented.
Results indicated a statistically and clinically significant decrease in
intensity and frequency of preoccupations and rituals for 12 of the 17
participants, based on YBOCS-BDD scores. The entire sample met
criteria for at least one personality disorder; however, no relationship was
demonstrated between treatment outcome and number or type of
personality diagnosis.
Newell and Shrubb (1994) discuss the successful cognitivebehavioral treatment of two female clients who refused to participate in
exposure treatment. Individual therapy consisted of reverse role-plays, or
"mock trials", in which the client presented arguments for the
attractiveness of the body part and the therapist presented evidence
against that argument. For one client, no other attempt was made to
challenge cognitions or to encourage exposure, whereas exposure
exercises were integrated during the latter treatment stages for the
second individual. Self-rated problem severity and strength of negative
beliefs decreased dramatically following treatment for both clients.
Two studies have examined the effects of CBT when conducted in
a group setting. In one study of 54 women diagnosed with BDD, half
were randomly assigned to a no-treatment control group, while the
remainder underwent eight weekly 2-hour sessions of group CBT. Groups
consisted of four to five clients and one therapist (Rosen et at, 1995).
Compared to the control group, post-treatment scores for CBT clients

improved significantly on several measures including the BDDE, YBOCSBDD, and the Body Shape Questionnaire. In addition, the treatment
group improved significantly over time on each measure, as demonstrated
by follow-up performance. Clinically significant improvement also was
demonstrated in that clients no longer met criteria for diagnosis and had
scores on measures of BDD symptomatology lower than the pretreatment
score minus two standard errors of measurement. However, as in the
Neziroglu and Yaryura-Tobias (1993b) study, all measurements were selfreport. Wilhelm, Otto, Lohr, and Deckersbach (1999) also have
demonstrated the effectiveness of group CBT for BDD. Thirteen clients
were assigned consecutively to small groups that met for 12 weekly 90minute sessions. Compared to pre-treatment assessments, clients
experienced a significant improvement in BDD symptoms and depression
levels. Similar results for group CBT also have been demonstrated with a
Spanish sample (Raich, Soler, & Mora, 1995). According to the above
studies, CBT administered in group settings appears to be a promising
format for therapeutic change.
Finally, two studies have been conducted examining either ERP or
CT alone. McKay and colleagues examined the effectiveness of ERP in
the absence of cognitive strategies, as well as the benefits of a
maintenance program following the completion of treatment (McKay,
Todaro, Neziroglu, Campisi, Moritz, & Yaryura-Tobias, 1997). Ten
participants attended ERP sessions five days per week for six weeks.
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Results demonstrated significant improvements on general measures of
BDD symptoms, depression, and anxiety. Five of the 10 participants who
received a maintenance program following treatment demonstrated lower
levels of general anxiety and depression compared to controls, and all
individuals remained "symptom free" (p.67) at follow-up. Secondly,
Geremia (1997) conducted a treatment study utilizing cognitive therapy
consistent with Beck's (1967) model. Four clients were randomly
assigned to one of two multiple baseline designs. Condition 1 consisted
of three weeks of baseline data collection followed by seven weeks of
cognitive therapy and a five week follow-up assessment. The second
condition involved five weeks of baseline collection, seven weeks of
treatment, and a three week follow-up. Results were analyzed using
techniques specifically designed for single-subject experimental research.
Three of the four clients demonstrated a significant reduction in
depression, anxiety, and body dissatisfaction following treatment.
However, only two of those clients reported a significant reduction in the
intensity and frequency of BDD-related obsessions and compulsions, as
evidenced by scores on the YBOCS-BDD. Visual inspection of those
individual cases demonstrated a very gradual improvement in BDD
symptoms following cognitive therapy.
In summary, research has demonstrated that a cognitive-behavioral
treatment package, administered in individual or group format, decreases
BDD-related obsessions, behaviors, and negative affect. In addition,

when treatment consists solely of cognitive therapy, reduction in
obsessions and compulsions occurs in some individuals. What has not
been explained, thus far, is why cognitive therapy is successful only in
some cases. If cognitive therapy is not effective for all individuals,
perhaps behavior therapy would be a viable alternative; or perhaps a
combination of cognitive and behavioral techniques is needed in some
cases. The one study that examined pure behavior therapy demonstrated
decreases in symptoms for all individuals, however, the measures were
general in nature and do not provide information on individual differences.
In short, we do not know what approaches are best with certain
individuals, or what factors influence the effectiveness of behavioral
versus cognitive techniques. In addition, there exists little information
regarding the processes that change during the course of behavior or
cognitive treatment. The current study investigates these processes of
change through examining daily changes in BDD-related cognitions and
behaviors over the course of both behavior and cognitive therapy.
Methodological Issues
Single-participant desiqns. In designing the current study, some
methodological issues required consideration. One such decision
centered around single-case versus group designs, and the
appropriateness of each for the current questions under investigation. In
the literature, discussions regarding the usefulness of single-subject
designs versus group methodology have examined the relative

contributions of each and the specific types of information that each
provides (Barlow & Hersen, 1987; Kazdin, 1982; Lundervold & Bellwood,
2000; Morgan & Morgan, 2001). While group designs allow for the
comparative testing of two treatments, single case experimental data
provide detailed information regarding the processes or mechanisms of
change during the course of a successful treatment. For many decades,
single-subject designs have been chosen as a means to investigate
psychological phenomena preliminary studies (Morgan & Morgan, 2001).
In fact, Kazdin (1982) has argued that preliminary investigations into
treatment effectiveness should first utilize single-subject designs and
focus on the process information that is yielded. Then, only once the
mechanisms of change have been identified, should group designs be
employed to investigate the overall efficacy of one treatment versus
another. The body of BDD outcome literature stands at this preliminary
state. Therefore, because change mechanisms of successful cognitivebehavioral treatment have not yet been identified, the current study
utilized a single-participant design to examine processes that change over
the course of both cognitive therapy and behavioral treatment. The
following section discusses the characteristics of single-case designs,
their advantages and disadvantages, and addresses issues regarding the
scientific rigor of single-participant versus group designs.
Single-participant designs are characterized by the repeated
measurement of dependent variables over the course of an experimental

manipulation. Although single-case designs may replicate these
manipulations across additional participants, data analysis does not
combine results across individuals to produce group averages. Instead,
the goal is to examine the detailed development of behavior across time
within a single individual, and to draw strong inferences about functional
relationships through intra- and interparticipant replications (Morgan &
Morgan, 2001).
Although single-participant designs do not traditionally utilize the
null hypothesis testing common to group designs, they are rooted in the
scientific method and can produce very rigorous and meaningful results
(Barlow, Hayes, & Nelson, 1984; Leitenberg, 1973; Morgan & Morgan,
2001). For example, an important goal of scientific research is the
demonstration of the experimental criterion. This criterion refers to the
method of data evaluation used to determine whether an intervention has
a reliable effect on behavior. Typically, the experimental criterion entails a
comparison of behavior under varying conditions, such as intervention
and nonintervention (Kazdin, 1984). Thus, in order for a series of singlesubject designs to demonstrate scientific rigor, data must be evaluated in
such a way as to meet the experimental criterion.
Several such methods exist for single-case data that allow for the
inference of causal relationships. Commonly, the visual inspection of
detailed graphs, in which data points are plotted across separate phases,
is used to evaluate reliable change (Baer, 1977; Michael, 1974). Such

"eyeballing" of the data may appear to be subjective and lacking in the
usual scientific standards that guide decision-making. However, for visual
inspection to be properly conducted, specific data requirements must be
met. In addition, the process of visual inspection and the conclusion of
reliable behavior change are governed by specific criteria, such as
changes in trend and latency of change (Kazdin, 1982; Parsonson & Bear,
1978). Cause and effect relationships between intervention and behavior
change may be inferred if such design requirements are met (Kazdin,
1984). In fact, many proponents of single-participant designs argue that
effects are only meaningful if clearly observable by visual inspection
(Hopkins, Cole & Mason, 1998; Parsonson & Baer, 1986; Perone, 1999;
Skinner, 1969). Thus, although some traditional Fisherian techniques are
available for small N designs, they are considered to be ill-fitted and to
undermine basic premises of single-case methodology (Lundervold &
Bellwood, 2000; Perone 1999).
As mentioned earlier, scientific rigor of the single-subject
experimental design is increased by the fundamental characteristic of
repeated measurement (Barlow, Hayes, & Nelson, 1984). Repeated
assessments of the dependent variable are crucial in examining individual
variability across baseline and treatment phases, and are necessary in
identifying trends in the behavior of interest. In fact, the addition of
repeated measurement to anecdotal case study is argued to be sufficient
for upgrading to a quasi-experimental design (Browning & Stover, 1971).
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In addition, repeated assessment allows for more ease in separating the
treatment effect from measurement error and other extraneous variables
(Barlow, Hayes, & Nelson, 1984). The detailed information provided
through repeated measurement is an advantage of single-subject designs
that is often lost in group studies, which typically assess the dependent
variable only before and after treatment, and at follow-up.
Another advantage to the single-subject design is the consideration
of variability as valuable information in the examination of intraindividual
changes. This approach to measurement allows for a more specific
understanding of the factors that control an individual (Barlow, Blanchard,
Hayes, & Epstein, 1977). Such a perspective is contrary to the view of
group designs, in which variability is seen as error that must be explained.
In most between-groups designs, measurements are conducted pre- and
post-treatment. An average group response is calculated, and the
amount that each individual differs from that average is considered
intersubject variability, or error. A weak treatment effect may be the result
of averaging the responses of clients who improve, deteriorate, or remain
constant (Barlow & Hersen, 1987). By contrast, the single case design,
because it incorporates variability into meaningful data, increases the
understanding of individual behavior. Not only is this valuable and
practical information lost in between-groups analyses, but the
consideration of variability as error may mask actual differences.
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The single subject experimental design also addresses the ethical
issue of withholding treatment in treatment versus no-treatment group
studies. When clients are suffering, there is an ethical dilemma in placing
them in a waitlist control group. Many scientist-practitioners struggle with
the decision to place a suffering client in a no-treatment group, yet a
comparison group is necessary to demonstrate the effectiveness of a
treatment manipulation (Barlow, et al., 1977; Barlow & Hersen, 1987).
Single case methodology allows for the examination of interventions on an
individual basis, in which individual behavior in a treatment phase is
compared to baseline measurements of that same client. Thus, the need
for a no-treatment group is reduced to a few weeks of baseline datagathering. In fact, proponents of single-case designs argue that the
comparison of a participant's behavior during the experimental phase to
that of the baseline phase is more meaningful because in natural settings
a clients' behavior is compared to pre-treatment behavior, not with the
behavior of other clients.
The most prominent difficulty with single-subject experimental
designs is external validity, or generalizability of findings. Questions may
arise as to whether information gained from the response of one client will
be relevant to the treatment of other cases, or whether other clinicians
would achieve similar results (Barlow et al., 1977). However, the use of a
between-groups design does not ameliorate this difficulty. Problems also
exist in generalizing from group results to an individual client. Hersen and

Barlow (1976) state that "the more adequate the sample, in that all
relevant population characteristics are represented, the less relevance will
this finding have for a specific individual" (p.55). The idea is that a more
representative sample equals a more heterogeneous one, and that the
average group response, therefore, will be less likely to generalize to that
of an individual client. Barlow and colleagues (1977) refer to this
hypothetical average client as the "nonexistent average" (p.224). Thus,
group designs are not necessarily the answer to the external validity
issue, as the treatment effect for a particular client may be lost in the
group average.
The current study implements the single-case methodology of the
multiple baseline technique. In this design, baseline responses are
measured over time before any manipulation is conducted. These
baselines differ in length across clients. Following the baseline, the
intervention is conducted, and measures of the same dependent variable
are taken. Thus, response changes that follow the treatment may be
compared to baseline behaviors (Baer, Wolf, & Risley, 1968). The
purpose of the multiple baseline is to correct for methodological
weaknesses of the simple phase change. In a simple phase change
where responses are measured during one baseline length and one
phase of treatment, there is no protection against coincidental, extraneous
events that influence behavior. In such cases, the researcher cannot be
confident that changes in responding are due to the intervention. For

example, an effect demonstrated by Participant 1 may be due to an
external influence that occurs during treatment. The multiple baseline
methodology replicates the phase change with other clients, allowing for
improved internal validity.
Another benefit of the multiple baseline design is the ability to
control for assessment or time-related changes. The varying lengths of
baselines act as controls for each other, in that such effects should be
evident in each baseline. However, if treatment effects are demonstrated
following the different baseline lengths, then one may be more confident
of internal validity (Barlow et al., 1984). Thus, multiple baselines across
clients improve confidence in treatment effects by arranging phase
changes so that between series comparisons are possible.
The current study also utilizes a crossover component in
combination with the multiple baselines. In a crossover design, two series
or conditions are synchronized such that two phase changes occur
concurrently, but in the reverse order. In other words, clients in one
condition will receive behavioral treatment followed by cognitive therapy,
whereas individuals in the remaining condition will undergo cognitive
therapy followed by behavioral treatment. An advantage to the crossover
design is that control over external factors is increased through changing
phases after the same number of sessions. Thus, consistent effects
shown within both conditions are more convincing than simple,
unsynchronized phase changes. One disadvantage to the crossover
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design, however, is order effects. Because one treatment is followed by a
second, it is uncertain whether effects demonstrated in the second phase
are due to the second treatment or to delayed effects of the initial
intervention. Despite this uncertainty, crossovers provide important
information concerning the effectiveness of the first-order treatment and
the combination of both treatments.
Response covariation. The examination of change mechanisms is
enhanced by identifying how different symptoms change in relation to
each other over the course of treatment. Response covariation refers to a
relationship between two responses such that a change in one response
affects changes in the other (Kazdin, 1982). Such covarying of responses
could result in therapeutic benefit, in that symptoms that are difficult to
target may be treated indirectly through more easily targeted responses
(Parrish & Roberts, 1993). For example, overvalued ideations found in
OCD are thought to be resistant to challenging and to respond poorly to

cognitive therapy (Kozak & Foa, 1994), yet behavioral treatment has been
demonstrated to reduce the believability of obsessions (Lelliot et al.,
1988). Thus, one symptom may be addressed therapeutically through the
targeting of an alternate symptom. For example, in the case of BDD,
cognitive therapy may have little effect on reducing preoccupations with
appearance and the frequency of negative self-statements. However, if
negative self-statements covary with BDD-related behaviors (e.g., mirrorchecking), then a reduction in such behaviors may cause a change in
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those cognitive statements. Thus, through response covariation, BDDrelated obsessions that are resistant to cognitive therapy may be targeted
indirectly through the treatment of related behaviors.
Thus far, no methodologically rigorous studies have examined the
effects of behavior therapy on BDD-related cognitions. However, in one
case study of relaxation training (Munjack, 1978), the client reported a
subjective decrease in preoccupations. Also, in a series of case studies
discussing the effects of ERP (Marks & Mishan, 1988), some clients did
report a decrease in previously unshakable beliefs. Unfortunately, several
of those participants began pharmacotherapy during the behavioral
treatment and, therefore, improvement in symptoms cannot be attributed
to behavior therapy. Geremia (1997) examined the effects of cognitive
therapy on BDD symptoms, and demonstrated that the targeting of BDDrelated cognitions resulted in a reduction of compulsive behaviors for two
of the four participants. In addition, the OCD outcome literature
demonstrates that successful behavior therapy reduces frequency and
believability of obsessions (Foa & Goldstein, 1978; Ito, et al., 1995, Lelliot
et al., 1988).
Thus, the identification of covarying clusters of symptoms may aid
in more effective treatment by revealing alternative and indirect treatment
targets. First, however, there is a need to identify these components or
processes that must be changed. In other words, before we investigate
whether a change in negative self-statements will affect change in
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compulsive checking behaviors, we need to determine whether frequency
of checking must change before treatment is successful. The current
study examines daily changes in cognitions and behaviors throughout the
course of therapy in order to identify whether changes in these processes
are required for successful treatment. In addition, the covariation of
cognitions and behaviors are examined over the course of both cognitive
and behavioral treatment in order to investigate whether targeting of one
process affects changes in the other. The covariation of BDD-related
behaviors and cognitions over the course of behavior and cognitive
therapies will be examined in the current study.
Current Study
The current study investigated particular aspects of behavioral and
cognitive theories of BDD through examining daily changes in behaviors
and cognitions over the course of behavior and cognitive therapies.
In keeping with the fear maintenance stage of Mowrer's two-factor
theory, behavioral theory for BDD states that BDD-related behaviors are
maintained through negative reinforcement. As discussed previously,
rituals (e.g., mirror-checking) and avoidance behaviors (e.g.,
camouflaging) are hypothesized to decrease discomfort elicited by
appearance-related thoughts and situations, and are maintained because
of their ability to decrease the aversive response. In addition, the
performance of these behaviors artificially decreases discomfort and
prevents the natural habituation process. If this theory were accurate, then

interrupting the reinforcing properties of rituals and avoidance through
ERP would result in an overall decrease in BDD-related behaviors. The
BDD outcome literature has demonstrated that a combination of ERP and
CT reduces BDD symptoms. However, a detailed investigation on the
effects of ERP alone on reducing overall BDD behaviors has not been
conducted.
In the OCD outcome literature, ERP has been shown to decrease
OCD-related behaviors, cognitions, and associated distress. Therefore, if
these change processes can be extrapolated to BDD, then a successful
course of ERP would be expected to reduce unhelpful cognitions and
negative affect, as well as behavior. The current study conducts a
detailed investigation into processes that change over the course of ERP,
and examines procedures consistent with the theory that BDD-related
behaviors and cognitions are maintained through negative reinforcement
patterns.
Although the implementation of ERP often improves OCD
symptoms, it would be erroneous to assume that the only mechanism for
improvement could be an interruption in negative reinforcement patterns
and habituation of a learned response. Other theories have been
proposed as possible explanations for the therapeutic effect of ERP. For
example, emotional processing theory (Rachman, 1980) and its
adaptation to anxiety disorders (Foa & Kozak, 1991) proposes that
exposure therapy achieves its gains through the modification of a fear

structure. Emotional processing involves the integration of information
into an existing fear structure that is incompatible with the pathological
elements of that structure. Exposure therapy is proposed to provide that
incompatible information, allowing for a reduction in fear by changing the
meaning of the feared event by demonstrating a reduction in the
probability of harm, while also allowing habituation of the physiological
response (Foa & Kozak, 1991).
Similarly, self-efficacy theory (Bandura 1986; 1988) states that
fearful behaviors arise from low self-efficacy (i.e., lack of belief in one's
own coping abilities in the face of fearful stimuli). The change mechanism
of exposure therapy is believed to be an increased sense of mastery
following the successful completion of exposure trials. Yet another
possible explanation for the success of behavior therapy could be the
altering of cognitions following a successful ERP trial and subsequent
increase in activity. Thus, several possible explanations exist for the
therapeutic success of ERP, preventing a definitive test of behavioral
theory in the current study.
Alternately, cognitive theory of BDD states that BDD symptoms are
maintained through a combination of distorted thinking patterns and
ongoing negative self-statements. In addition, Beck's general cognitive
theory (from which BDD cognitive theory was derived) proposes that the
most effective point of intervention to change cognitions, behaviors, and
affect lies with altering the cognitions. Therefore, cognitive theory

proposes that overall therapeutic change results from reductions in
cognitive distortions and negative self-statements. The current study
investigates the theory that BDD symptoms are maintained through
cognitive distortions and negative self-statements by investigating whether
these statements decrease over the course of cognitive therapy.
However, as with the testing of behavioral theory, challenges exist
with empirically testing the validity of BDD cognitive theory. That is,
results demonstrating effective cognitive therapy, while consistent with the
theory, would not prove that proposed change mechanisms were the
actual maintaining factors. In other words, cognitive therapy could result
in amelioration of BDD symptoms through entirely different processes
other than those assumed by cognitive theory. For example, McFall and
Wollersheim (1979) proposed that individuals with OCD match the
perceived threat of an event with their ability to cope, and that the
challenging of expected catastrophic outcomes allows for a more
appropriate match between threat and coping ability. Alternately,
discussions regarding the effectiveness of cognitive therapy for OCD have
noted that cognitive therapy often requires behavioral experiments or
naturally leads to an increase of behavioral activity (Abromowitz, 1997).
Thus, the fact that cognitive therapy may be effective through
mechanisms other than the alteration of maladaptive schemas makes the
testing of that theory difficult.
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Also of importance is determining the particular aspects of the CBT
package that result in symptom relief. In very practical terms, the
identification of crucial components and the elimination of extraneous
elements are time- and cost-effective. In addition, the inclusion of
unnecessary elements could serve to dilute the overall effectiveness of
the treatment by guiding efforts away from the most crucial aspects of
intervention. For example, if the proposed investigation determined that
cognitive challenging did not contribute in a clinically significantly manner
to the reduction of BDD symptoms, then therapeutic efforts could center
on behavioral exercises. Thus, the identification of necessary treatment
components could make for a more powerful and effective intervention.
The current study examined clinically significant change following both
behavior and cognitive therapies.
Using a multiple baseline series, six clients were randomly
assigned to one of two conditions. Clients in Condition One underwent
baseline assessment, followed by eight bi-weekly sessions of CT, another
period of baseline assessment, and eight bi-weekly sessions of BT.
Clients in Condition Two underwent the same sequence of baseline and
treatment, but received BT as the initial treatment followed by CT (Figure
1).

Within each condition, clients were assigned to one of three
multiple baselines. Baseline One involved one week of baseline
measurement followed by the first treatment, three weeks of baseline, and

the second treatment. Baseline Two entailed two weeks of baseline
measurement, treatment, two weeks of baseline, and treatment. Finally,
clients in Baseline Three underwent baseline measurement for three
weeks, followed by treatment, one week of baseline, and treatment.
Throughout the study, three measurements were conducted on a daily
basis: an idiosyncratic behavior (e.g., frequencylduration of mirrorchecking) was monitored daily to assess behavioral change; a frequency
count of negative self-statements was recorded daily to assess cognitive
change; and a rating of global distress was recorded daily to assess
affective change. Thus, the daily measures of cognition, behavior, and
affect provided a very detailed picture of changing processes throughout
the two treatments. In addition to these daily measurements, a semistructured clinical interview and a battery of BDD-related measures were
administered at all phase change points throughout the study, and thirdparty ratings were collected weekly.
Hvpotheses Related to Behavior Therapy
Hypothesis 1: Behavior therapy will result in decreases in daily
frequencies of appearance-related compulsions.
Hypothesis 2: Behavior therapy will result in deceases in daily
frequencies of appearance-related negative self-statements.
Hvpothesis 3: During behavior therapy, the reduction in daily
negative self-statements will not be as great as the reduction in daily
compulsive behaviors.

Hypothesis 4: Behavior therapy will result in decreases in daily
distress levels.
Hypotheses Related to Coqnitive Therapy
Hvpothesis 5: Cognitive therapy will result in decreases in daily
frequencies of appearance-related negative self-statements.
Hypothesis 6: Cognitive therapy will result in decreases in daily
frequencies of appearance-related compulsions.
Hypothesis 7: During cognitive therapy, the reduction in daily
compulsive behaviors will not be as great as the reduction in daily
negative self-statements.
Hvpothesis 8: Cognitive therapy will result in decreases in daily
distress levels.
Hvpothesis Related to Combined Coqnitive and Behavioral Therapies Hypothesis 9
Both behavior therapy and cognitive therapy are predicted to be
necessary for clinically significant change. Neither behavior therapy nor
cognitive therapy alone will be sufficient in decreasing BDD-related
symptoms to a clinically significant degree.

Chapter 2
METHOD
Participants
Participants were two males and three females, ranging in age
from 21 to 44, who met diagnostic criteria for BDD. Education level
ranged from high school completion to a Masters degree. A sixth male
participant began the study but discontinued. Participants were recruited
from both Maine and Manitoba communities through local advertisements
and through referrals from other mental health professionals. The
diagnosis of BDD was determined using the Body Dysmorphic Disorder
Examination (BDDE, Appendix A; Rosen & Reiter, 1996). The BDDE is a
semi-structured clinical interview designed for diagnostic purposes, and
for assessing the presence and severity of BDD symptoms. Four of the
six participants were taking medication for psychological disorders at the
time of this study, and were permitted to participate provided they were
stabilized on the medication for at least four weeks. Exclusion criteria
included the diagnosis of anorexia nervosa or a psychotic disorder, active
alcohol or substance abuse, and concurrent psychotherapy.
Therapists
Two clinical psychology interns and one clinical psychology
doctoral student conducted the individual therapy sessions, and were
supervised by a licensed clinical psychologist. All three therapists had a
background in cognitive-behavior therapy, and were further trained in the
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cognitive-behavioral models of BDD and treatment techniques specific to
the disorder. In addition, training was conducted regarding the design of
the study, and therapists followed a detailed treatment manual.
Adherence to the treatment protocol was monitored through individual
supervision sessions that followed each therapy session.
Measures
Total Compulsive Behavior Score (TCBS). On a daily basis, clients
were asked to record compulsive behaviors. The daily score represented
the number of compulsive behaviors performed or total amount of time
spent ritualizing in a given hour. The particular behavior and hour in
which measurement was taken were chosen on an idiographic basis and
remained consistent throughout the entire study. For example, if the most
prominent ritual was mirror-checking, then the participant recorded the
number and/or the duration of checks during the same hour each day.
The TCBS was calculated by summing the minutes spent ritualizing or the
number of behaviors conducted in that hour. Appendix B presents the
behavior measured for each participant. A reduction in the TCBS was
used as an indication of treatment success.
Total Neqative Self-statements Score (TNSS). On a daily basis,
clients were asked to record the number of negative appearance-related
self-statements during a chosen hour. Clients were provided with a
mechanical counter, and asked to record every occurrence of a negative
self-statement during this hour. As with the TCBS, the measurement hour
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was chosen on an idiographic basis, and reflected the hour in which these
thoughts were most frequent. The TNSS was calculated by summing the
number of negative thoughts in that hour, and a reduction in this score
was considered indicative of treatment success.
Global Distress Rating (GDR). For the third daily measure, clients
were asked to record their average level of distress throughout the entire
day. Ratings were to range from 0 to 100, and a reduction in this score
was considered indicative of treatment success.
Third Partv Measure. On a weekly basis, participants were asked to obtain
additional data from a person who lived with the client and who was knowledgeable
about the appearance concerns. Once a week, the participant was provided with a
form (Appendix C) requesting the third party to (i) rate on a 10-point scale the average
amount of effort the participant exerted that week related to appearance concerns, and
(ii) indicate the number of times the participant asked for reassurance that day.
Body Dvsmorphic Disorder Examination (BDDE). The BDDE
(Appendix A; Rosen & Reiter, 1996) is a 32-item semi-structured clinical
interview designed as a diagnostic instrument, as well as a tool for
assessing typical BDD symptoms that may be targeted for treatment. A
total score of 60 or greater (out of a possible score of 166) is indicative of
the presence of BDD. The interview taps into self-consciousness and
preoccupation with physical appearance, overvalued ideations about the
importance of appearance in self-evaluation, avoidance of social
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situations or exposure of the appearance defects, and body camouflaging
and body checking behaviors.
The BDDE has demonstrated satisfactory reliability and validity
(O'Grady, Thorpe, & Kubik, 1998; Rosen & Reiter, 1996), good test-retest
reliability (1 = .96 for two-week period), inter-rater reliability (1= -94 to .98),
and internal consistency (1= .93). The BDDE correlated significantly with
other measures of BDD, and successfully discriminated clients referred for
body image problems from non-clinical individuals with body image
complaints and normal controls (Rosen & Ramirez, 1998; Rosen & Reiter,
1996).
The Yale-Brown Obsessive Compulsive Scale for Body
Dysmorphic Disorder (YBOCS-BDD). The YBOCS-BDD (Appendix D;
Phillips, Hollander, Rasmussen, Aronowitz, DeCaria, & Goodman, 1997)
was adapted from the YBOCS (Goodman, Price, Rasmussen, Mazure,
Fleischmann, et al., 1989), a widely used measure of obsessive
compulsive disorder. The self-report version of the YBOCS-BDD consists
of 10 items that measure time spent engaging in BDD-related obsessions
and compulsions, as well as the intensity of distress, amount of
interference in daily functioning, and the level of subjective control over
obsessions and compulsions. Each item is rated on a 0- to 4-point scale,
with separate scores calculated for the obsession and compulsions
subscales.
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The clinical interview version of the YBOCS-BDD showed good
internal consistency (1= .80) and test-retest reliability (1 = .88 for one week
interval). Total scores on the YBOCS-BDD were significantly correlated
with scores on the Clinical Global Impression Scale but not the Brief
Psychiatric Rating scale, indicating adequate convergent and discriminant
validity. Sensitivity to symptom improvement was demonstrated with 26
clients following a 16-week pharmacological trial (Phillips et al., 1997).
The Appearance Schemas Inventory (ASI). The AS1 (Appendix E;
Cash & Labarge, 1996) is a 14-item, self-report measure designed to
assess beliefs and assumptions concerning the importance, meaning, and
effects of appearance on one's life. Items are rated on a five-point scale
of "strongly disagree" to "strongly agree." The AS1 demonstrates
acceptable internal consistency (coefficient alpha = .84; Cash & Labarge,
1996). Good construct validity was shown through moderate to high
correlations with other body-image measures (1 = .48 to .64) and unique,
incremental variance over and above those measures (R-squared = .57;
p<.001). In addition, the AS1 differentiated between clinical body-image
groups and non-clinical groups. An investigation of the factor structure
revealed three factors that were termed body-image vulnerability, selfinvestment, and appearance stereotyping.
The Social Avoidance and Distress Scale (SADS). The SADS
(Appendix F; Watson & Friend, 1969) is a 28-item, truelfalse measure
designed to assess distress associated with social and interpersonal
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situations, as well as the behavioral avoidance of those situations. The
maximum possible score is 28, with higher scores indicative of higher
levels of anxiety and poor adjustment to social environment.
The SADS demonstrates acceptable internal consistency (.77 to
.94; Robinson, Shaver, & Wrightsman, 1991) and test-retest reliability (.68
to .94 over four week period; Watson & Friend, 1969). A correlation of .45
between the social and evaluative scales of the S-R Inventory of
Anxiousness (Endler & Hunt, 1966) demonstrated adequate convergent
validity. Discriminant validity was demonstrated with the Affiliation Scale
of Jackson's (1966, as cited in Geremia, 1997) Personality Research
Form (r = -.76).
The Overvalued Ideas Scale (OVIS). The OVlS (Appendix G;
Neziroglu. Yaryura-Tobias, McKay, Stevens, & Todaro, 1998, as reported
in Geremia 1997) is a nine-item, self-report inventory that assesses the
degree to which individuals believe that particular fears are realistic and
compulsions are necessary. Each item is rated on a scale of one to ten,
with higher ratings indicating greater overvalued ideation. Good internal
consistency (1 = .96) was demonstrated using a group of 48 individuals
diagnosed with OCD. Convergent validity was indicated with a significant
correlation (1: = .69) between the OVlS total score and a YBOCS item that
assesses insight into obsessive-compulsive symptoms. The correlation of
a depression scale with the OVlS (1 = -.12) demonstrated discriminant
validity.
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The Beck Depression Inventory- II (BDI-11). The BDI-II (Appendix
H; Beck, Steer, & Brown, 1996) is a 21-item, self-report questionnaire that
taps into the cognitive, affective, behavioral, and biological features of
depression. Each item is rated on a 0- to 3-point scale of severity, with
higher ratings indicating greater severity of symptoms. Total scores on
the BDI-II may describe an individual as severely, moderately, or mildly
depressed. Low scores indicate the absence of depression.
The BDI-II is psychometrically sound (Beck et al., 1996). The
instrument demonstrates good internal consistency (alpha = .92) and testretest reliability (1 = .93). Significant correlations with scales that measure
depressive symptoms (Beck Hopelessness Scale, r = .68; Hamilton
Psychiatric Rating Scale for Depression, 1= -71) and significant, but
lower, correlations with anxiety measures (Hamilton Rating Scale for
Anxiety, I = .47) indicate convergent and discriminant validity. A principal
components analysis identified two factors, termed Somatic-Affective
(standardized-regression coefficients 2 .35)and Cognitive (.33).
Desiqn
Six clients were randomly assigned to one of two conditions
(Appendix I). Clients in Condition One received eight sessions of CT,
followed by the same number of BT sessions, whereas participants in
Condition Two underwent the same treatments but in the reverse order.
Within each condition, participants were assigned to one of three initial
baseline periods (one, two, or three weeks). A second baseline

assessment period was implemented at the midpoint of treatment (i.e.,
following treatment one and prior to treatment two). These midpoint
baselines also differed in length (three, two, or one weeks), depending on
the number of initial baseline weeks, to amount to four weeks of total
baseline assessment time. Baseline One involved three weeks of
baseline measurement followed by the first treatment, one week of
assessment, and the second treatment. Baseline Two entailed two weeks
of baseline, treatment, two weeks of measurement, and treatment.
Finally, clients in Baseline Three underwent baseline assessment for
three weeks, followed by treatment, one week of baseline, and treatment.
During baseline assessment, two measurements were conducted.
An idiosyncratic behavior (e.g., duration of mirror-checking) was
monitored daily to assess behavioral change, whereas cognitive change
was monitored with a daily frequency count of negative, appearancerelated self-statements. In addition, a battery of outcome measures was
administered repeatedly throughout the study (Appendix J).
Procedure
Assessment. Individuals responding to study advertisements were
screened on the telephone for appropriateness in the study.
Respondents who were diagnosed with anorexia nervosa or a psychotic
disorder or those who had an active alcohol or substance abuse problem
were considered inappropriate for the study, and were referred elsewhere
for services. Individuals who described preoccupations with appearance
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defects that interfered with daily functioning were invited to participate in a
more comprehensive, face-to-face interview. For those individuals who
were taking medications for psychological disorders, the interview was
scheduled once a stable dosage for four weeks had been maintained.
During the interview, the BDDE was administered in order to
determine whether participants met criteria for BDD. Once a diagnosis of
BDD had been determined, clients were invited to take part in the
research study. Participants were informed about the procedures of the
study and were given a consent form to read and sign. Those individuals
who did not meet these criteria offered referrals to other mental health
practitioners.
In keeping with single-case methodology, assessment continued
frequently throughout treatment. As discussed above, each client
participated in a pre-treatment baseline assessment. Daily counts of both
rituals and negative cognitions were recorded throughout the baseline
period, as well as during both behavioral and cognitive phases of
treatment. In addition to the daily recordings of specific symptoms, a
battery of measures was administered at each phase change (Appendix

J). The battery included the YSOCS-SDD, SDI-ll, OVI, Appearance
Schemas Inventory, and SADS. The BDDE interview also was conducted
at phase changes in order to assess whether individuals still met criteria
for the disorder.

Behavior therapy. Behavior therapy consisted of eight one-hour
sessions twice per week. Session 1 was psychoeducational in nature and
explained BDD in terms of the behavioral model. A behavioral analysis of
antecedents, consequences, and avoidance behaviors was conducted
and discussed with the client. Then, a rationale for ERP was discussed,
and a detailed hierarchy of anxiety-provoking ERP exercises was
developed in a collaborative manner. Hierarchy items included both insession and homework scenarios and focused on the exposure of the
body part in public situations and the prevention of anxiety-reducing
rituals. Examples of ERP hierarchy items included creating a fake pimple
on face while avoiding mirror-checking or covering-up, wearing a formfitting shirt to a busy waiting area while refraining from covering-up or
fleeing the area, and allowing the therapist to stare at lips while avoiding
talking or placing hand in front of mouth.
Throughout Sessions 2 to 8, ERP exercises were conducted in a
graduated manner, both in session and as homework. Once hierarchy
items were selected, clients were instructed to remain in the situation until
discomfort decreased, without using the traditional distress-relieving
compulsions. Distress levels were measured by the Subjective Units of
Distress Scale (SUDS; Appendix K). The SUDS is a 100-point Likert
rating scale in which zero represents 'no anxiety' and 100 represents
'worst possible anxiety.' Clients were asked to record SUDS ratings at
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approximately two-minute intervals throughout ERP exercises. ERP trials
were discontinued once SUDS ratings decreased to 20 to 30.
The initial ERP trial was conducted in the presence of the therapist
in order to ensure proper execution of the exercise. Because of the
distressing nature of ERP, clients tend to terminate the exercise
prematurely, or to engage in other anxiety-reducing techniques (e-g., selftalk). Therefore, clients were reminded continually of the rationale for
ERP and the beneficial nature of experiencing the anxiety as fully as
possible. Progression to the next hierarchy level followed participants'
sense of mastery on lower-rated items.
Cognitive therapy. Cognitive therapy was provided in eight onehour sessions twice a week. Clients receiving CT underwent cognitive
restructuring procedures based on the principles of Beck's model of
cognitive therapy (Beck, 1995). Session 1 was predominantly
psychoeducational in nature and described BDD in terms of the cognitive
model. Participants were provided with a list of cognitive distortions
common among those with BDD (Geremia, 1997; Appendix L), and
idiosyncratic cognitive errors were postulated. Details about the perceived
defect and the resulting distress were discussed, as well as the impact on
social and occupational functioning. Dysfunctional attitudes and unhelpful
automatic thoughts were explored in a preliminary manner, along with
discussion surrounding developmental antecedents of body image

problems, sociocultural and familial factors, and immediate sources of
body image distress.
In Sessions 2 through 8, participants kept daily thought diaries
(Appendix M) in which they recorded automatic thoughts, fluctuations in
mood, situational details, and resultant changes in behavior. For
example, a client may write, "I was having coffee with my friend and she
was staring at my hair. I bet she thought my hair was too fuzzy and that
no one else would want to be my friend. I am so ugly and stupid. I felt
embarrassed and told her I had to leave." Then, these recordings were
discussed and evaluated in session. The validity of disturbing automatic
thoughts was challenged, in a collaborative manner, by examining
evidence for and against the thought, determining alternative explanations
to the thought, and evaluating the importance of the thought on feelings.
The goal of such validity-testing was to challenge cognitive distortions
underlying the distressing automatic thoughts. Particular attention was
paid to the more damaging beliefs concerning the implications of
appearance for self-worth.
With practice, clients were encouraged to recognize maladaptive
automatic thoughts and cognitive errors, and to begin challenging their
validity throughout daily activities. As such skills were developed, clients
practiced generating more accurate thoughts to replace the negative selfstatements. Participants were encouraged to interrupt negative selfstatements as they occur, replace them with the more neutral thoughts,

and evaluate the effect on emotion. For example, the client discussed
above may challenge her beliefs that she was an ugly and unwanted
friend by thinking "if I really were that ugly then my companion wouldn't be
able to tolerate sitting across from me", and "if no one wanted to be my
friend then I wouldn't receive the social invitations that I do." This
challenging could eventually lead to the generation of more accurate
replacement thoughts, such as "my hair is fluffy and curly [versus fuzzy
and ugly]", and "friends enjoy my company."
Once participants demonstrated an ability to challenge cognitive
distortions, CT progressed to the identification of more underlying core
beliefs. Thus, automatic thoughts were pursued in order to identify the
connection between physical appearance and inherent character traits
(e.g., lovability, worthiness). Once identified, the validity of core beliefs
(e.g., "I am worthless"; "I am unlovable") was challenged with the goal of
altering the underlying schema.
Follow-up Assessment
Two months following the completion of treatment, a follow-up
assessment was conducted, including re-administration of the BDDE
diagnostic interview and battery of self-report measures.

Chapter 3
RESULTS
The following daily data were visually analyzed according to published
guidelines (Parsonson & Baer, 1978; Appendix N.), and questionnaire data were
analyzed in accordance with guidelines for computing clinical significance
(Jacobson & Truax, 1991; Appendix 0). With regard to BDDE scores, clinical
significance was demonstrated once the individual no longer met criteria for the
disorder. Due to order effects, hypotheses regarding the effects of BT or CT
were discussed in terms of participants who received that treatment as the initial
intervention. Case descriptions of the five participants and their qualitative
responses to treatment are presented in Appendix P.
Hvpotheses Related to Behavior Therapy
Clients 1, 2, and 3, received BT as the first treatment after varying
baseline periods (Client 1, 7 days; Client 2, 14 days; Client 3, 21 days). These
clients were used to test hypotheses regarding BT alone.
Hvpothesis 1. It was predicted that BT would result in behavior change as
demonstrated by a reduction in daily TCBS. Clients 2 and 3 demonstrated the
predicted drop in TCBS coincident with the introduction of BT. Client 1 did not
show the effect. (See Figures 1,2, &3; Tables 1,2, & 3).
During baseline, Client 2 demonstrated a wide range of TCBS (90-20; Figure 2),
with mean weekly baseline TCBS of 66 and 61 (Table 2). These behaviors
decreased over the course of BT, such that TCBS ranged from 25 to 2, with
TCBS consistently below 10 during the final week of BT. Mean weekly
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Fiqure 1. Daily Total Compulsive Behavior Scores (TCBS) across all phases for
Client 1.

Fiqure 2. Daily Total Compulsive Behavior Scores (TCBS) across all phases for
Client 2.
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Table 1.
Mean Weekly TCBS, TNSS, and GDR Across All Phases for Client 1
BSL 1

BT 1

BT2

BT3

BT4

BSL2

BSL3

BSL4

TCBS

9

16

11

7

7

12

9

13

TNSS

11
60

17
72

10
69

6
65

9
52

7
49

5
44

7
46

GDR

Table 2.
Mean Weekly TCBS, TNSS, and GDR Across All Phases for Client 2
CT1

CT2

CT3

CT4

4

10

14

15

4

5

3

7

7

8

4

29

20

36

30

34

27

BSL 1

BSL2

BT 1

BT2

BT3

BT4

BSL3BSL4

66

61

25

14

14

12

7

21

25

12

10

12

6

64

39

38

41

37

23

TCBS
TNSS
GDR

Table 3.
Mean Weeklv TCBS, TNSS. and GDR Across All Phases for Client 3
BSL I

BSL2

BSL3

BT I

BT2

BT3

BT4

BSL4

CT1

CT2

CT3

CT4

16

9

6

3

4

1

2

0

0

1

0

0

5

4

2

1

1

0

1

0

0

1

0

0

60

37

41

32

35

32

32

21

17

19

14

13

TCBS
TNSS
GDR
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TCBS, during BT, ranged from 25 to 12. In addition, these low scores
continued throughout the second baseline and subsequent course of CT.
During baseline, Client 3 demonstrated a wide frequency range in TCBS
(30-0; Figure 3), with a slight downward trend (weekly means = 16 & 9; Table 3).
However, TCBS decreased in range over the course of BT (15-O), and remained
consistently at zero during the second baseline. TCBS also remained at a stable
low rate over the subsequent course of CT.
In addition, BT was predicted to result in decreases in third party ratings of
reassurance-seeking and behavioral effort. Unfortunately, third party ratings
were not available for any of these participants. Due their efforts to maintain
secrecy, none of these individuals had disclosed their concerns to the significant
others with whom they lived.
Hypothesis 2. It was predicted that that BT also would result in
cognitive change, as demonstrated by a decrease in daily TNSS. Client
3 demonstrated a reduction in TNSS over the course of BT. Clients 1 and
2 did not demonstrate the predicted effect. (See Figures 4, 5, & 6)
During baseline, Client 3 recorded a wide frequency range of TNSS (11-0;
Figure 6), with a slight downward trend (weekly means = 5, 4, & 2; Table 3).
TNSS decreased in range over the course of BT (4-0) for this client and
remained consistently at zero during the second baseline. TNSS remained at a
stable low rate over the subsequent course of CT.

BSL 2

Fiqure 4. Daily Total Negative Self-Statement Scores (TNSS) across all phases
for Client 1.

Figure 5. Daily Total Negative Self-Statement Scores (TNSS) across all phases
for Client 2.

Figure 6. Daily Total Negative Self-statement Scores (TNSS) across all phases
for Client 3.
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Hvpothesis 3. It was predicted that the reduction in daily negative selfstatements (TNSS) would not be as great as the reduction in compulsive
behaviors (TCBS). Client 2 and Client 3 did demonstrate greater decreases in
TCBS than TNSS over the course of BT. Client 1 demonstrated no change in
either TCBS or TNSS during the course of BT (See Figures 7, 8 , & 9).
Hypothesis 4. It was predicted that BT would result in reductions in
daily distress levels (GDR). Client 3 demonstrated a notable decrease in
GDR over the course of BT (See Figures 10,11,& 12).
During baseline, Client 3 endorsed a wide range of GDR (90-20;
Figure 12), with weekly means of 60, 37, & 41 (Table 3). GDR decreased
over the course of BT (range = 50 - 20), and decreased further during the
second baseline (range = 30-15). Client 1 demonstrated a moderate
decrease in GDR (Figure lo), whereas Client 2 did not demonstrate any
notable change in GDR over the course of BT (Figure 11).
Hypotheses Related to Coqnitive Therapy
Clients 4 and 5 received CT as the first treatment after varying baselines
(Client 4, 7 days; Client 5, 14 days). These clients were used to test hypotheses
regarding CT alone.
Hypothesis 5. It was predicted that CT would result in cognitive change,
as demonstrated by a reduction in daily TNSS. Client 5 demonstrated the
predicted decrease in TNSS over the course of CT (See Figures 13 & 14; Tables
4 & 5).

Figure 7. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative
Self-Statement Scores (TNSS) across all phases for Client 1.
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Fiqure 8. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative
Self-Statement Scores (TNSS) across all phases for Client 2.

Fiqure 9. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative
Self-statement Scores (TNSS) across all phases for Client 3.

Figure 10. Daily Global Distress Ratings (GDR) across all phases for Client 1.
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Figure 12. Daily Global Distress Ratings (GDR) across all phases for Client 3.

Fiqure 13. Daily Total Negative Self-Statement Scores (TNSS) across all
phases for Client 4.
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Fisure 14. Daily Total Negative Self-Statement Scores (TNSS) across all
phases for Client 5.

Table 4.
Mean Weekly TCBS, TNSS, and GDR Across All Phases for Client 4

TCBS

11

9

10

9

10

TNSS

1 GDR

1

75

I

71

72

I

I

70
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Table 5.
Mean Weekly TCBS, TNSS, and GDR Across All Phases for Client 5
BSL I

BSL2

CT 1

CT2

CT3

CT4

BSL3

BSL4

BTI

BT2

BT3

BT4

2

2

2

2

2

2

2

2

2

1

2

2

3

2

1

1

1

0

0

1

0

1

1

0

54

44

33

40

28

24

22

26

25

27

12

18

TCBS
TNSS
GDR
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During baseline, Client 5 demonstrated a moderate frequency range of
TNSS (6-0; Figure 14), with mean weekly baseline TNSS of 3 and 2 (Table 5).
As predicted, TNSS decreased in range over the course of CT (2-O), with mean
weekly TNSS ranging from 1 to 0. In addition, these low scores continued
throughout the second baseline. Client 4 did not demonstrate a decrease in
TNSS over the course of CT.
Hypothesis 6. It was predicted that CT also would result in
behavior change as demonstrated by a reduction in daily TCBS and a
reduction in third party measures of behavioral effort. Neither Client 4 nor
Client 5 demonstrated decreases in TCBS over the course of CT (Figures
15 & 16; Tables 4 & 5). However, compared to baseline, Client 5 did
demonstrate a decrease in third-party ratings of reassurance-seeking
(Figure 17) and behavioral effort (Figure 18) over the course of CT. The
recording of third party ratings was considered inappropriate for Client 4
due to the current abuse by her significant other.
Hypothesis 7. It was predicted that the reduction in daily
compulsive behaviors (TCBS) would not be as great as the decrease in
negative self-statements (TNSS). Client 5 demonstrated a greater
decrease in TNSS than TCBS over the course of CT (Figure 20). Client 4
demonstrated no change in either TNSS or TCBS during the course of CT
(Figure 19).

Figure 15. Daily Total Compulsive Behavior Scores (TCBS) across all phases
for Client 4.

Figure 16. Daily Total Compulsive Behavior Scores (TCBS) across all phases
for Client 5.
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Fiqure 17. Number of reassurance-seeking behaviors recorded by a third party
over a one day per week period for Client 5.
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Fiqure 18. Weekly average ratings of appearance-related behavioral effort
recorded by a third party for Client 5.

Fiqure 19. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative
Self-Statement Scores (TNSS) across all phases for Client 4.
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Fiqure 20. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative
Self-Statement Scores (TNSS) across all phases for Client 5.
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Hypothesis 8. It was predicted that CT would result in reductions in
daily distress levels (GDR). Client 5 demonstrated a decrease in GDR
during the end of the CT period (See Figures 21 & 22). During the
baseline, Client 5 recorded a wide range of distress ratings (76-20; Figure
22), with weekly means of 54 and 44 (Table 5). As predicted, overall
distress decreased such that, during the final week of CT, GDR ranged
from 36 to 15 with a mean of 24.
Client 4 did not demonstrate a decrease in distress ratings over the
course of CT (Figure 21, Table 4).
Hypothesis Related to Combined Coqnitive and Behavioral Therapies Hypothesis 9
It was predicted that both BT and CT would be necessary to result
in clinically significant reductions on self-report measures and on the
structured interview. Details regarding the computation of clinical
significance are presented in Appendix N.
As predicted, Client 5 demonstrated clinically significant reductions
on the YBOCS-BDD and BDI-II following the completion of both CT and
BT (Table 6). In addition, Client 5 no longer met criteria for BDD following
the completion of both treatments, as determined by BDDE scores.
Clinically significant decreases were not demonstrated for the ASI, OVIS,
or SADS.

Figure 21. Daily Global Distress Ratings (GDR) across all phases for Client 4.
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Fisure 22. Daily Global Distress Ratings (GDR) across all phases for Client 5.

Table 6.
Questionnaire and Structured Interview Data for Client 5
PREBSL

PRECT

POSTCT

PREBT

POSTBT

FOLLOWUP

BDDE

104

105

65

68

40++

31++

YBOCSBDD
AS I

22

20

13

14

9+

8+

2.85

2.50

2.36

2.57

2.14

2.29

OVlS

8.38

8.5

5.75

5.88

2.88

6.38

SADS

24

24

24

24

10

8

BDI-II

23

27

17

17

6+

10

+ clinically significant improvement
++ no longer meets criteria for BDD

Also as predicted, Client 2 demonstrated clinically significant
improvement following the completion of both treatments, as determined
by BDDE and BDI-II scores (Table 7). However, Client 2 also showed
clinically significant reductions in YBOCS-BDD scores following the
completion of BT only. This improvement in YBOCS-BDD scores was
maintained throughout CT and at follow-up.
Client 3 met criteria for clinically significant improvement following
completion of BT only, as determined by scores on the BDDE and YBOCS-BDD
(Table 8). These improvements in BDDE scores were maintained throughout CT
but lost at follow-up. The reductions in YBOCS-BDD scores were lost
immediately following the completion of BT.
Client 1 and Client 4 did not demonstrate clinically significant reductions
on any of the self-report measures (Tables 9 & 10).

Table 7.
Questionnaire and Structured Interview Data for Client 2
PREBSL

PREBT

POSTBT

BDDE

62

65

65

YBOCSBDD
AS I

22

23

1O+

2.29

2.29

1.86

OVlS

4.13

4.13

4.38

SADS

21

21

18

BDI-II

24

23

18

PRE-

I

POST-

I FOLLOW-

+ clinically significant improvement
++ no longer meets criteria for BDD

Table 8.
Questionnaire and Structured Interview Data for Client 3
PREBSL

PREBT

POSTBT

PRECT

POSTCT

FOLLOWUP

BDDE

74

89

57

41++

35++

50

YBOCSBDD
AS I

26

28

9+

13+

17

17

3.36

3.36

3.00

2.86

3.21

2.93

OVlS

4.63

5.88

3.00

2.75

3.50

3.75

SADS

25

21

17

16

18

14

BDI-II

26

31

18

20

20

13

+ clinically significant improvement
++ no longer meets criteria for clinically significant change

Table 9.
Questionnaire and Structured Interview Data for Client 1
--

PREBT

P0,STBT

PRECT

POSTCT

FOLLOWUP

7
YBOCS-

Table 10.
Questionnaire and Structured Interview Data for Client 4

BDDE

PREBSL
134

PRECT
126

POSTCT
120

PREBT
113

POSTBT
128

FOLLOWUP
128

YBOCSBDD
AS I

32

34

37

35

33

30

4.71

4.36

3.79

4.50

4.50

4.29

OVlS

8.50

9.13

7.50

8.63

7.88

8.88

SADS

26

25

26

27

27

27

BDI-II

40

40

37

43

40

32

Chapter 4
DISCUSSION
The current study utilized a multiple baseline, treatment crossover
design to investigate the effects of cognitive and behavioral therapies on
the reduction of BDD symptoms and the implications of these results on
behavioral and cognitive theories of BDD symptom maintenance.
Following a careful diagnostic screening, six individuals diagnosed with
BDD as the primary disorder were invited to participate. Five participants
completed the study. These participants received eight twice-weekly onehour sessions of either behavior or cognitive therapy, followed by the
same number of sessions of the other treatment. Although results
demonstrated wide variability, behavior therapy appeared to be more
effective in reducing daily ratings of negative thoughts, compulsive
behaviors, and global distress. In addition, for three of the five
participants, clinically significant improvement was demonstrated following
the combination of both cognitive and behavior therapy. Results were
more consistent with the behavioral theory of BDD symptom maintenance.
Implications for Behavioral Theorv of BDD
The current study investigated implications for behavioral theory of
BDD symptom maintenance, which states that BDD rituals and avoidance
responses are maintained through negative reinforcement. Through
interrupting the reinforcing properties of the behaviors and allowing the
habituation process to occur, overall frequencies of BDD-related

behaviors were hypothesized to decrease. In addition, OCD outcome
literature has demonstrated that ERP reduces OCD-related cognitions
and associated distress. Thus, in the current study, ERP also was
hypothesized to decrease the daily frequencies of negative appearancerelated self-statements and overall distress levels.
Results were consistent with behavioral theory. Following behavior
therapy, one participant improved notably on all three daily measures of
behaviors, thoughts, and distress, whereas another improved notably on
the daily measure of behaviors. In addition, although both behavior
therapy and cognitive therapy were hypothesized to be necessary for
clinically significant improvement on questionnaire measures, behavior
therapy alone demonstrated clinically significant decreases for two
participants on the YBOCS-BDD, one of whom no longer met criteria for

BDD following behavior therapy. Furthermore, although definitive
conclusions cannot be made due to order effects, one client who received
cognitive therapy as the initial treatment demonstrated clinically significant
reductions in YBOCS-BDD and BDI-II scores only after behavior therapy
had been introduced. Also, this individual no longer met criteria for BDD
following the completion of behavior therapy.
One of the three participants who received behavior therapy as the
first treatment did not demonstrate improvement on any of the daily
measures nor self-report questionnaires. Although this individual
appeared to understand the therapeutic principles and to engage fully in

treatment, she did not demonstrate symptom change. The reasons for
this lack of improvement remain unclear.
In summary, results make a case for the behavioral theory of BDD. In
keeping with studies of behavior therapy for BDD (Marks & Mishan, 1988; McKay
et at., 1997), the exposure to feared situations and the prevention of ritual
completion often resulted in the reduction of daily compulsive behaviors, as well
as related thoughts and distress. In addition, results are consonant with ERP
outcome literature for OCD (Foa & Goldstein, 1978; Ito, et al., 1995; Lelliot, et
al., 1988), which demonstrates effectiveness in reducing compulsions and, to a
lesser degree, frequency of obsessions and strength of conviction in obsessional
beliefs. Importantly, however, are the other theories of ERP that could
potentially explain therapeutic effects. For instance, as previously mentioned,
the success of behavior therapy also could be a consequence of an altered fear
structure (Foa & Kozak, 1991), changes in cognitions, or improvements in selfefficacy (Bandura, 1986, 1988). Thus, although the current results are
consistent with the behavioral model of BDD, a definitive conclusion regarding
the impact of reinforcement contingencies cannot be drawn.
Implications for Cognitive Theon/ of BDD
The current study also investigated the cognitive theory of BDD
symptom maintenance, which states that BDD symptoms are maintained
through distorted thinking patterns and ongoing negative self-statements.
Due to the interactive nature of cognition, behavior, and affect, the
challenging of distorted assumptions was hypothesized to result in a

decrease in daily negative self-statements, BDD-related behaviors, and
associated distress.
Results were partially consistent with cognitive theory. Following
cognitive therapy, one participant improved notably on daily measures of
thoughts, distress, and third party ratings of behavioral effort and
reassurance-seeking. However, for this individual, decreases in daily
behavioral avoidance were not exhibited as a result of cognitive therapy.
In addition, clinically significant reductions on the YBOCS-BDD, BDDE,
and BDI-II scores were not demonstrated until a course of ERP had been
completed. Unfortunately, however, definitive conclusions regarding the
separate effects of cognitive or behavior therapy on these particular
improvements cannot be drawn due to order effects.
The second participant who received cognitive therapy as the first
treatment demonstrated no improvement on daily measures, self-report
questionnaires, or the clinical interview. At the time of the study, this
individual also was suffering from intense distress associated with
extreme physical, verbal, and psychological abuse experienced in
childhood. In addition, during the study, she charged her husband with
physical assault (which was the culmination of years of physical abuse)
and accidentally found her daughter attempting suicide/homicide through
carbon monoxide poisoning by locking herself in the garage with her one
year-old child. These additional factors were believed to be influential in
the lack of treatment response by impeding therapeutic engagement.
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This individual was too distressed to complete homework exercises and
was often too distracted to fully engage in in-session therapeutic
exercises. Thus, therapeutic success was thought to be impeded by
these factors.
In summary, results were somewhat consistent with the cognitive
theory for BDD. The challenging of cognitive distortions improved daily
negative self-statements and global distress for only one of two
participants, and did not reduce daily avoidance or result in clinically
significant improvement in self-report measures. Mixed results for
cognitive therapy also were demonstrated in a previous BDD outcome
study (Geremia, 1997). In that study, cognitive therapy resulted in a
reduction in BDD-related thoughts and behaviors for only two of the four
participants. It is important to realize, however, that poor treatment results
do not necessarily refute the theory due to other potential impediments.
For instance, in the current study, the opportunity for replication was not
as available for the CT-BT condition because the third participant dropped
out of the study following cognitive therapy and did not return any data.
Therefore, the second replication available for the BT-CT condition was
not possible. In addition, the complexity of cognitive therapy may require
a much greater number of sessions before effectiveness is demonstrated.
Although results have been interpreted within the cognitive model
of BDD, the potential impact of other therapeutic factors prevents firm
conclusions regarding the altering of maladaptive schemas. As previously
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discussed, other theories have proposed crucial change mechanisms of
effective cognitive therapy. For instance, an improved match between
perceived threat and coping ability (McFall & Wollersheim, 1979), as well
as a subsequent increase in behavioral activity (Abromowitz, 1997) have
been hypothesized causes for improved symptoms following cognitive
therapy. Thus, a firm conclusion supporting cognitive theory of BDD could
not have been possible in this study.
Response Covariation
Predictions were also made regarding the covariation of BDDrelated thoughts and behaviors. As previously discussed, response
covariation during cognitive and behavior therapies has been
demonstrated in a preliminary manner (Geremia, 1997; Marks & Mishan,
1988). However, this research has focused on pre-post or periodic
measurements with self-report measures. The current study is the first to
examine fluctuations in daily thoughts and behaviors over baseline and
treatment phases.
Evidence for daily covariation of intrusive thoughts and compulsive
behaviors/avoidance was mixed. Two participants demonstrated strong
covariation of thoughts and behaviors over both baseline and treatment
phases. Client 3 exhibited similar fluctuations in thoughts and behaviors
during baseline, followed by a gradual decrease in both over the course of
behavior therapy. Thus, for this individual, behavior therapy was sufficient
in reducing compulsive mirror-checking as well as negative self-

statements. In addition, the strong connection between thoughts and
behaviors may be seen during the following phase of cognitive therapy, in
which a 45-day absence of both negative self-statements and mirrorchecking was interrupted by a one-day rise in both thought and behavior
scores. Although Client 1 did not improve notably throughout the study,
the link between mirror-checking and negative self-statements was clearly
demonstrated. Daily scores for both thoughts and behaviors fluctuated
widely throughout baseline and treatment phases, with increases and
decreases in one score closely following the other.
None of the other three participants demonstrated a clear
covariation between thoughts and behaviors. Client 2 exhibited a
decrease in distracting behaviors over the course of behavior therapy,
which remained throughout the following baseline and cognitive therapy
treatment phase. However, negative self-statements did not notably
decrease over the course of the study. For Client 5, although negative
self-statements and third party ratings of behavioral effort decreased over
the course of cognitive therapy, levels of avoidance behaviors remained
relatively stable. In addition, over the subsequent course of behavior
therapy, levels of avoidance decreased slightly while negative selfstatements slightly increased. Finally, Client 4 did not demonstrate
improvement over the course of the study.
Traditionally, and in this study, competing cognitive and behavioral
theories of treatment success have been discussed as separate and

distinct theoretical models. However, reports of the relatively equal
effectiveness of ERP and cognitive therapy in the treatment of OCD
(Emmelkamp & Beens, 1991; Emmelkamp, et al., 1988; van Oppen et al.,
1995) have led to speculation regarding mechanisms of change and the
validity of such separate theoretical distinctions. Abromowitz (1997)
suggested two possible explanations. One possibility is that behavior
therapy and cognitive therapy achieve similar effects through specific and
separate psychological mechanisms. Alternately, these two treatments,
considered to be from separate theoretical approaches, may actually
share a common psychological mechanism. It has been suggested that
the separate mechanisms approach would be supported if cognitive
therapy resulted in significantly more cognitive than behavioral change,
and vice versa (Abromowitz, 1997). Currently, available data do not
support the existence of separate mechanisms for OCD. Likewise, the
covariation demonstrated in the present study does not support the idea
of separate mechanisms for BDD.
Effects of Combined Cosnitive-Behavioral Treatment
In keeping with BDD outcome research, three participants
demonstrated improvement in several domains following the completion of
both cognitive and behavioral treatments. At post-CBT and a two-month
follow-up, Client 5 no longer met criteria for BDD and demonstrated
clinically significant reductions on measures of BDD symptom severity and
depression. In addition, daily measures of negative cognitions and global

distress, as well as third party assessments of behavioral effort and
reassurance-seeking decreased notably over the course of CBT. At postCBT and follow-up, Client 2 demonstrated clinically significant decreases
on measures of BDD symptom severity and depression and, at follow-up,
no longer met criteria for BDD. In addition, Client 2 demonstrated a
notable reduction in daily frequencies of compulsive behaviors. Finally, at
post-CBT, Client 3 exhibited notable decreases in daily measures of
negative cognitions, compulsive behaviors, and global distress, and no
longer met criteria for BDD. The remaining two participants did not
improve during the study.
The results of this study provide previously unknown information
regarding the necessary components of CBT. Because cognitive and
behavioral therapies were conducted separately and in succession,
effects of the first-order treatment versus the combined treatment may be
evidenced. Of the three participants who improved, behavior therapy
appeared to be the pivotal component in effecting clinically significant
change. The improvements gained by Client 2 and Client 3 on
questionnaires of symptom severity and daily measures of cognition,
behavior, and distress were largely demonstrated following the completion
of behavior therapy as the initial treatment and maintained through the
course of cognitive therapy. Client 5, who received behavior therapy as
the second treatment, demonstrated clinically significant change on
measures of BDD symptoms and depression only once behavior therapy
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had been completed. Unfortunately, definitive conclusions regarding the
cause of those particular improvements cannot be drawn, as the reduction
of symptoms could be attributable to either the introduction of behavior
therapy or carry-over effects of cognitive therapy. However, the
information provided by Client 5 is consistent with results from the
additional two participants, which appear to support the behavioral
therapy of BDD.
Thus, although some evidence supporting cognitive therapy was
demonstrated, the current study lends more support to the behavioral
therapy of BDD.
Relation To Other Studies
Results of the current study were consistent with many published
findings. First, as with several studies of CBT (Neziroglu & YaryuraTobias, 1993; Neziroglu et al., 1996; Rosen et al., 1995; Wilhelm, 1999),
the combined effects of cognitive challenging and ERP improved BDD
symptoms and depression for some individuals. Due to the use of several
commonly used measures (e.g., BDDE, YBOCS-BDD, and BDI-II), similar
rates of improvement following CBT are exhibited between the current
study and previous research (Neziroglu & Yaryura-Tobias, 1993;
Neziroglu et al., 1996; Rosen et al., 1995; Wilhelm, 1999). In addition, the
resistance to treatment demonstrated in the above studies, has been
replicated here. Current results are consistent with discussions

(Neziroglu, 2000) regarding minimal results often obtained despite high
numbers of treatment sessions.
The current data also mirror preliminary results on the effects of
ERP and cognitive therapy as separate treatments. McKay and
colleagues demonstrated that ERP alone is sufficient in reducing BDD
symptoms and depression (McKay et al, 1997). Although the current
study cannot claim to show symptom reduction in all participants,
consistency can be concluded through the ability of ERP alone to reduce
BDD and depressive symptoms in two out of three individuals. In
addition, similarity with Geremia (1997) may be seen in the lesser effects
of cognitive therapy as a sole treatment. Although cognitive therapy did
result in some daily symptom reduction for one client, it did not lead to any
clinically significant decreases on the YBOCS-BDD or other self-report
measures. Similarly, in Geremia's study, only one of four participants
improved on YBOCS-BDD scores following cognitive therapy. Thus,
results of the present study are consistent with both treatment
improvements and treatment challenges recorded in the outcome
literature.
Mechanisms of Change
In an attempt to identify potential mechanisms for therapeutic
improvement (i.e., decreases in thoughts or behaviors), the daily changes
occurring during successful treatment were examined. Of the three
participants who improved to a clinically significant degree, each exhibited
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a different pattern of daily symptom improvement. Following CBT, Client

2 did not meet criteria for BDD and demonstrated clinically significant
reductions in YBOCS-BDD and BDI-II scores. During treatment, he
recorded notable decreases in compulsive behaviors but no such
reduction in negative self-statements. Following behavior therapy, Client 3
no longer met BDD criteria and demonstrated clinically significant
improvement in YBOCS-BDD scores. Congruently, he also recorded
notable reductions in daily thoughts and behaviors. Surprisingly, however,
he lost these gains in clinically significant improvement during cognitive
therapy and follow-up, but maintained the decrease in daily thoughts and
behaviors. Finally, following CBT, Client 5 did not meet criteria for BDD
and demonstrated clinically significant improvement in YBOCS-BDD and
BDI-II scores. During treatment, she recorded decreases in daily negative
self-statements but no notable improvements in avoidance behaviors.
Given the inconsistent patterns of change across participants, no
generalized conclusions can be drawn regarding the mechanisms for BDD
symptom change. It appears as if different mechanisms may operate for
different individuals. Anecdotally, clients have been reported to
demonstrate little reduction in BDD-related thoughts coincident with
successful treatment, but instead report a decrease in negative meaning
attached to those thoughts (Neziroglu. 2000). Thus, perhaps a decrease
in negative self-statements is an indicator of success for some, but for
others it is the ability to think "my nose is big and ugly, but who cares?"

Another possibility is a lack of connection between negative selfstatements and compulsive behaviors, such that a decrease in distressprovoking thoughts leads to clinically significant improvement but allows
for some compulsive behaviors to remain. For others who demonstrate a
decrease in daily thoughts and behaviors but who still meet criteria for

BDD, the important factor may be the ability of the remaining cognitions
and rituals to create intense distress. In this case, the change mechanism
would not be frequency reduction but perhaps affective reduction. These
issues remain unclear.
Sensitivitv of Measures
Although improvements were demonstrated by several participants
on behavioral, cognitive, and affective measures, such progress was not
reflected by other self-report questionnaires employed in the study. This
raises questions regarding the sensitivity of those measures. For
example, no improvements in AS1 scores were demonstrated by any
participant. The AS1 was designed to assess beliefs and assumptions
concerning the importance, meaning, and effects of appearance on one's
life. Despite the fact that all participants exhibited clinically significant
distress and impairment stemming from appearance-related concerns,
three of the five participants' pre-treatment scores fell within the normal
range. Further examination revealed that the normative data for the AS1
were obtained from a sample of female college students, which may have

inflated the mean artificially. Therefore, the AS1 may not have been an
appropriate measure of BDD treatment change.
Despite obvious gains in social and occupational functioning for
several participants, clinically significant improvements were not
demonstrated on the SADS, a measure designed to assess distress and
avoidance associated with social and interpersonal situations. For
example, prior to treatment, Client 3 had been virtually housebound and
rarely left his bedroom for fear of being seen by others. He had
discontinued post-secondary education and had recently been divorced
due to appearance-related difficulties. During the final treatment
sessions, he made regular trips to a music store, went out on a date, and
re-enrolled in school. The SADS failed to detect these changes in social
functioning. Perhaps the general, trait-like items, such as "I tend to
withdraw from people" or "I feel relaxed even in unfamiliar situations," are
incapable of detecting more specific, yet clinically significant, changes in
social and interpersonal functioning. An additional difficulty with the
SADS is the rectangular distribution and large standard deviation found in
the normal sample, which prevents the clinical significance criteria (i.e.,
the post-treatment score must be two standard deviations below the mean
of the normal sample) from being met.
Finally, the detection of daily change for Client 5 was hampered by
the particular nature of her symptom presentation. Whereas other
participants experienced higher frequencies of thoughts, Client 5
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experienced fewer but extremely distressing self-statements regarding her
appearance and self-worth. This floor effect hindered the demonstration
of more dramatic reductions in daily negative thoughts. In addition, the
determination of a measurable daily behavior was not possible because
she did not engage in any overt rituals such as mirror-checking.
Therefore, an inverse measure of daily avoidance was chosen, which may
have affected the ability to demonstrate reliable reductions.
Limitations of the Studv
Inherently present in crossover designs, order effects result in
methodological limitations for treatment studies. Due to the fact that the
initial treatment is followed by a second type of therapy, it is uncertain
whether effects demonstrated in the second phase are due to the second
treatment or to delayed effects of the initial intervention. Conclusions can
only be drawn regarding the effect of the first treatment and the effect of
the two treatments combined. Therefore, in the current study,
interpretations regarding cognitive therapy cannot be made for Clients 1
through 3 who received behavior therapy as their initial treatment.
Likewise, results from Client 4 and Client 5 cannot provide information on
the effects of behavior therapy alone. However, the crossover design is
ideal for comparing the initial treatments to the package intervention and
was, therefore, chosen as an important component of the current design.
As discussed previously, one important benefit of the multiple
baseline design is the increase in confidence it provides in drawing

conclusions. Unlike single-phase change designs, multiple baselines
provide protection against time- and environmentally-related effects.
Thus, the varying baselines allow for greater confidence in interpreting
post-baseline symptom improvement. Unfortunately, in the current study,
baseline data sometimes demonstrated wide variability and occasional
decreases in scores. Although this could arguably detract from the
interpretation of results, the severity and long-term nature of these
individuals' symptoms provides support for treatment effectiveness. For
example, Client 3 demonstrated wide variability in frequency of negative
self-statements, with a moderate decrease toward the end of the threeweek baseline period. The remote potential of spontaneous improvement
exists. However, severe BDD symptoms had been present for at least
seven years and had led to suicide attempts and inpatient
hospitalizations. In addition, he had experienced little relief following
seven years of pharmacotherapy and numerous courses of supportive
counseling. Therefore, a more likely interpretation of the baseline
decrease could be an increased sense of hope or self-efficacy due to the
preliminary participation in the study or contact with a mental health
professional who understood a frequently unrecognized disorder. The
ineffectiveness of previous supportive counseling argues against the
influence of nonspecific effects in the symptom reduction demonstrated
following behavior therapy.

Treatment Failures
Although improvements were demonstrated in several realms, the
present results concur with recent outcome literature in the varied and
inconsistent nature of treatment success. Two participants did not
improve on any of the outcome measures. Possible explanations for this
lack of improvement have been discussed above. Client 2 did not
improve on daily measures of negative thoughts or global distress,
whereas Client 5 did not improve on daily measures of behaviors. Client
3 no longer met criteria for BDD and demonstrated clinically significant

improvement on the YBOCS-BDD following a course of behavior therapy
but that improvement was lost and never regained once treatment
switched to cognitive therapy. In addition, Client 3 never demonstrated
clinically significant improvement on a measure of depression.
Previous treatment studies of BDD have revealed similar patterns
(Geremia, 1997; Neziroglu et al., 1996; Rosen et al., 1995; Veale et al.,
1996; Wilhelm et al., 1999). In addition, it has been noted that statistically
significant improvement in BDD symptoms is an insufficient criterion for
treatment success, due to the extremely high scores on outcome
measures and the debilitating nature of symptoms (Neziroglu, 2000).
Thus, the more meaningful, and sometimes more stringent, criterion of
clinically significant improvement has been recommended. Perhaps the
focus on clinically significant changes in the current study may explain the
varied results on questionnaire measures.
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Clinical Implications
Although behavior therapy appears to be more effective in reducing BDD
symptoms and related difficulties, cognitive treatment also has been
demonstrated to result in some therapeutic change. This is important knowledge
due to the aversive nature of exposure therapy and clients' frequent reluctance
or refusal to participant (Newell & Shrubb, 1994). Preliminary findings regarding
cognitive therapy suggest that such an approach would be a viable option for
clients refusing to engage in exposure exercises. In addition, cognitive therapy
may be viewed as an appropriate strategy for initial sessions, to allow for rapportbuilding and for reducing the rigidity of beliefs that may be preventing the
acceptance of behavior therapy. One client from the current study who had
received cognitive therapy as the first treatment stated that she would not have
been willing to engage in exposure exercises prior to cognitive treatment. She
stated that challenging the cognitive distortions provided evidence against the
catastrophic conclusions, and that she was able to draw on that evidence to gain
strength for exposure trials. Of course, these conclusions were retrospective.
Conclusions
The present study was the first to explore behavioral and cognitive
theories of symptom maintenance, and the first to examine daily changes
in thoughts, behaviors, and affect during behavior and cognitive therapy of
BDD. Results were consistent with the behavioral theory of BDD
symptom maintenance. For two out of three participants, interrupting the
reinforcing properties of ritual and avoidance behaviors and allowing the

115

natural course of habituation to take place resulted in a decrease in daily
BDD-related symptoms. In addition, selected results were consistent with
the cognitive maintenance theory. For one of the two participants, the
challenging of cognitive distortions and negative automatic thoughts led to
a more limited decrease in some daily symptoms. Although these results
have been interpreted within specific behavioral and cognitive
frameworks, they do not refute other interpretations of symptom
maintenance.
Results of the combined CBT package replicated previous BDD
outcome studies. Following the completion of both treatments, three of
the five no longer met criteria for the disorder, and two maintained this
improvement at a two-month follow-up. In addition, two of the five
demonstrated clinically significant reductions on measures of BDD
symptoms and depression. A third participant also achieved a clinically
significant decrease on the BDD symptom measure, but lost those gains
once treatment was switched from behavior to cognitive therapy.
Behavior therapy appeared to be the more important component in
effecting clinically significant improvement.
For most clients, the covariation of BDD-related thoughts and
behaviors was demonstrated across baseline and treatment phases. This
information is very useful for the treatment of BDD, due to the strength of
conviction often exhibited in BDD-related beliefs. For one client, ERP
alone was sufficient in drastically reducing negative appearance-related

self-statements. Finally, results were inconclusive regarding the
mechanism of change in successful BDD treatment.
Future Directions
The current study involved a total of 16 one-hour sessions held
twice per week and broken down into eight behavior therapy and eight
cognitive therapy sessions. Although this design was chosen to
investigate the relative effects of cognitive and behavior therapy
compared to the combined package, the total number of sessions per
modality may have been too abbreviated. Future designs examining daily
changes in symptoms could include a behavior therapy condition andlor a
cognitive therapy condition to allow investigations of a more complete
course of each therapy. For example, rather than implementing a
prescribed number of sessions, behavior therapy could be conducted until
changes in compulsive behaviors occur. Likewise, a parallel condition
could provide cognitive therapy until changes in negative self-statements
are demonstrated. Such an investigation would prevent a premature
termination of the treatment that could mask imminent effects, allowing
sufficient time for the identification of delayed treatment changes. In
addition, this type of design would enhance ecological validity, as it would
more likely reflect the delivery of treatment in a non-research setting.
Due to the high rate of BDD treatment failures, valuable information
could be provided by an intensive study of participants who did not
improve. In the current study, two individuals failed to demonstrate
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therapeutic changes, and possible explanations were discussed regarding
treatment engagement. Therefore, one potential approach would be to
examine treatment failures in terms of their ability to understand treatment
rationales and their ability to engage fully in the treatment at home and in
session. This could assist in determining whether therapeutic
engagement is a frequent impeding factor, or whether other factors
interfere with treatment once the client has engaged.
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Appendix A
Some Critical Interview Items on the BDDE
Has there been anything about your physical appearance which
you disliked over the past four weeks?
Over the past four weeks, to what extent have you felt that other
people have the same feature?
Over the past four weeks, have you inspected your
check the extent of the problem?

in order to

Over the past four weeks, how dissatisfied with your
have
you felt? Have there been days that you have been so dissatisfied it
has upset you?
Over the past four weeks, how dissatisfied with your appearance overall
have you felt?
Over the past four weeks, have you tried to get reassurance from others
that your
is not as bad or abnormal as you think it is?
Over the past four weeks, have you spent much time thinking about your
and feeling upset?
Over the past four weeks, how much have you worried about your
when you were in public areas?
Over the past four weeks, how much have you worried when you were in
social settings?
10. Over the past four weeks, how often have you felt that other people were
?
noticing or paying attention to your
II.
Over the past four weeks, how upset have you become when you felt
someone was noticing or paying attention to your
?

12.Over the past four weeks, how often has someone made either a positive
or negative comment on your
?
13. Over the past four weeks, how upset have you become when someone
commented on your
?
14.Over the past four weeks, how often have you been treatment differently
by others or in ways you didn't like because of your
?
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15. Over the past four weeks, how upset have you become when people
?
treated you in these ways because of your
16. Over the past four weeks, has your
yourself as a person?

influenced how you think about

17. Over the past four weeks, have you ever gotten down on yourself or felt
negatively about yourself as a person because of your
?
18. Over the past four weeks, did you ever feel other people judged you
negatively because of your
?
19. Over the past four weeks, how attractive physically do you feel other
people thought you were?
20. Over the past four weeks, have you ever thought that your
not be as bad as you generally think?

might

21. Over the past four weeks, have you avoided public areas because you felt
uncomfortable about your
?
22. Over the past four weeks, have you avoided work or social situations
because you felt uncomfortable about your
?
23. Over the past four weeks, have you avoided close physical contact with
.
others because of your
24. Over the past four weeks, have you deliberately dressed in any way to
?
cover up or disguise your
25. Over the past four weeks, have you deliberately controlled your posture or
body movements in order to hide your
?
with the
26. Over the past four weeks, have you compared your
appearance of other people around you or in magazines or television?

Appendix B
Participants' Behavioral Measures for the TCBS
Participant 1:

Number of mirror-checks conducted from 9:OOAM to
10:OOAM

Participant 2:

Number of distracting behaviors (e.g., covering
mouth, excessive talking, turning head) completed
during the entire day

Participant 3:

Number of mirror-checks conducted from 12:OOAM to
1:00AM

Participant 4:

Number of minutes spent mirror-checking from
10:OOAM to 11:00 AM

Participant 5:

Amount of avoidance for entire day measured by
computing the inverse of the number of leisurelfun
activities conducted in public that day

-

Appendix C
Third Partv Form
ID #:
Date:
Number of times today that your family memberlfriend has sought
reassurance about hislher appearance:

Please rate how much effort this week that your family memberlfriend has
put into behaviors related to hislher appearance.

no
effort

little
effort

moderate
effort

much
effort

extreme
effort

Appendix D
Yale-Brown Obsessive Compulsive Scale
Body Dvsmorphic Disorder Version
For each item, please circle the number that best describes the way you have felt
andlor behaved over the past week, including today.
1. On average, how much of your time during a given day is ocupied by
thoughts about a defect or flaw in your appearance or body parts such as
your hair, breasts, skin, teeth, genitals, hands, etc.?

0 - None (symptom free)
1 - Mild (less than 1 hour per day), or occasional thoughts
(occurring no more than 8 timeslday)
2 - Moderate (1-3 hours per day), or frequent thoughts (occurring
more than 8 times per day)
3 - Severe (3-8 hours per day), or very frequent thoughts
(occurring more than 8 times per day and during most hours of
the day)
4 - Extreme (more than 8 hours per day), or near constant
thoughts (too numerous to count and an hour rarely passes
without several such thoughts occurring)
2. How much do these thouqhts interfere with your social or work functioning?
Is there anything you don't do because of them?

0 - None (no recognizable interference)
1 - Mild (slight interference with social or occupational functioning,
but overall performance is not impaired)
2 - Moderate (thoughts are frequent and disturbing, but still
manageable)
3 - Severe (thoughts cause substantial impairment in social or
occupational functioning)
4 - Extreme (incapacitating)
3. How much distress do your thoughts about having appearance defects
cause?
0 - None (thoughts about body defects do not affect how I feel)
1 - Mild (thoughts are not very disturbing)
2 - Moderate (thoughts are frequent and disturbing, but still
manageable)
3 - Severe (thoughts are very frequent and very disturbing)
4 - Extreme (incapacitating)
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4. How much of an effort do you make to resist these thoughts? How often do
you try to resist or turn your attention away from these thoughts as they enter
your mind?

0 -Always try to resist these thoughts, or symptoms are so minimal
that it is not necessary to resist.
1 -Try to resist most of the time
2 - Make some effort to resist
3 - Yield to all such thoughts'without attempting to control them,
but do so with some reluctance
4 - Completely and willingly yield to all such thoughts
5. How much control do you have over your thoughts about your
appearance defects? How successful are you in stopping or diverting
these thoughts?

0 - Complete control
1 - Much control, thoughts are stopped or diverted with some effort
or concentration
2 - Moderate control, sometimes able to stop or divert these
thoughts
3 - Little control, rarely able to stop or divert these thoughts
4 - No control, completely out of control, thoughts are experienced
as involuntary and automatic
6. How much time do you spend in activities related to your concern over your
appearance or bodily defect (e.g., time spent trying to conceal the defect with
makeup, consulting plastic surgeons or dermatologists, looking in the mirror,
etc.)

0 - No time spent in these behaviors
1 - Mild (spend less than one hour per day in these activities)
2 - Moderate (1-3 hours per day, or no more than 8 times per day)
3 - Severe ( 3-8 hours per day), or frequent involvement (more
than 8 times per day)
4 - Extreme (more than 8 hours per day spent on these activities,
or near constant involvement)

7. How much do these activities interfere with your social or work functioning?
Is there anything you don't do because of them?
0 - None (no interference)
1 - Mild (slight interference with social or occupational functioning,
but overall performance is not impaired)
2 - Moderate (definite interference with social or occupational
functioning, but still manageable)
3 - Severe (activities cause substantial impairment in social or
occupational functioning)
4 - Extreme (incapacitating)
8. How would you feel if prevented from performing these activities (e-g., no
mittor-checking, makeup, camouflaging, consulting plastic surgeons or
dermatologists, etc.)? How distressed would you become?

0 - No distress
1 - Mild (would feel slightly anxious if such behaviors were
prevented)
2 - Moderate (anxiety would mount but remain manageable if such
behaviors were prevented)
3 - Severe (prominent and very disturbing increase in anxiety
would result of behaviors were prevented)
4 - Extreme (incapacitating anxiety would result from any
intervention aimed at modifying these behaviors)

9. How much of an effort do you make to resist these behaviors?

0 - Always try to resist these compulsions

1 - Try to resist most of the time
2 - Make some effort to resist
3 - Yield to almost all of these behaviors without attempting to
control them
4 - Completely and willingly yield to all behaviors related to
perceived appearance defect

10. How strong is the drive to perform these behaviors? How much control do
you have over them?
0 - Complete control
1 - Much control, able to exercise voluntary control over these
behaviors
2 - Moderate control, able to control these behaviors with some
difficulty
3 - Little control. very strong drive to perform these behaviors, can
delay these behaviors with considerable difficulty
4 - No control, completely and willingly yield to all behaviors
related to perceived appearance defect

Appendix E

AS Inventory
Indicate your beliefs about these items using the 1 to 5 scale:
Strongly
Disagree

Mostly
Disagree

Neither Disagree
Nor Agree

Mostly
Agree

1. What I look like is an important part of who I am.

Strongly
Agree

1 2 3 4 5

2. What's wrong with my appearance is one of the first
things people will notice about me.

1 2 3 4 5

3. One's outward physical appearance is a sign of the
character of the inner person.

1 2 3 4 5

4. If I could look just as I wish, my life would be mush happier.

1 2 3 4 5

5. If people knew how I really look, they would like me less.

1 2 3 4 5

6. By controlling my appearance, I can control many of the
social and emotional events in my life.

1 2 3 4 5

7. My appearance is responsible for much of what has
happened to me in my life.

1 2 3 4 5

8. 1 should do whatever I can to always look my best.

1 2 3 4 5

9. Aging will make me look less attractive.

1 2 3 4 5

10. For women: To be feminine, a woman must be as pretty
as possible.
For men: To be masculine, a man must be as handsome
as possible.

1 2 3 4 5

11. The media's messages in our society make it impossible
for me to be satisfied with my appearance.

1 2 3 4 5

12. The only way I could ever like my looks would be to change
what I look like.

1 2 3 4 5

13. Attractive people have it all.

1 2 3 4 5

14. Homely people have a hard time finding happiness.

1 2 3 4 5

Appendix F
Social Avoidance and Distress Scale
Please read each question and circle either T (true) or F (false).
1. I feel relaxed even in unfamiliar situations.

T/F

2. 1 try to avoid situations which force me to be sociable. T/F
3. It is easy for me to relax when with strangers.
have no particular desire to avoid people.
often find social occasions upsetting.

TIF
TIF

T/F

usually feel calm and comfortable in social situations. TIF
I am usually at ease when talking to someone of the opposite sex. TIF

8. 1 try to avoid talking to people unless I know them well.

TIF

9. If the chance comes to meet new people, 1 often take it. TIF
10. 1 often feel nervous or tense in casual get-togethers in which both sexes are
present. TIF
11. 1 am usually nervous with people unless I know them well.

TIF

12. 1 usually feel relaxed when I am with a group of people. TIF
13. 1 often want to get away from people.

TIF

14. 1 usually feel comfortable when I am in a group of people I don't know. TIF
15. 1 usually feel relaxed when I meet someone for the first time.

T/F

16. Being introduced to people makes me feel tense and nervous.

TIF

17. Even though a room is full of strangers, I may enter it anyway.

TIF

18. 1 would avoid walking up and joining a large group of people.
19. When superiors want to talk to me, I talk willingly.

T/F

20. 1 often feel on edge when I am with a group of people. TIF
21. 1 tend to withdraw from people.

TIF

TIF

22. 1 don't mind talking to people at parties or social gatherings.
23. 1 am seldom at ease in a large group of people.

TIF

T/F

24. 1 often think up excuses in order to avoid social engagements. TIF
25. 1 sometimes take the responsibility for introducing people to one
another. TIF
26. 1 try to avoid formal social gatherings. T/F

27. 1 usually go to whatever social engagements I have.
28. 1 find it easy to relax with other people.

TIF

TIF
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Appendix G
Overvalued Ideas Scale
List three of the main appearance related beliefs you have had in the past week
(e-g., I am unattractive, my nose is misshapen, my complexion is ruddy, etc.)

Please read each of the following questions. Rate each belief separately
according to the scale provided.
1. How strong is each belief?
< I-2-3-4-5-6-7-8-9-7
not very strong

O>
very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating
2. How reasonable is each belief?
< I -2-M-5-6-7-8-9-1
not very strong

O>
very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating
3. In the last week, what was the lowest rating for each belief?
<I-2-%5+7-&-%I
not very strong
Belief # I Rating
Belief #2 Rating
Belief #3 Rating

O>
very strong

4. In the last week, what was the highest rating for each belief?

< I-2-34-5-6-7-8-9-10>
not very strong

very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating

5. How accurate or reality based is each belief?

<1-2-345--6--7-8-9-10>
not very strong

very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating
6. How likely is it that others have the same belief about your appearance that
you do?

< 1-2-34-54-7-8-%I
not very strong

07
very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating

7. What is the likelihood that your compulsive (beautification remedies,
avoidance behaviors, mirror-checking, etc.) being effective in changing the
way you feel?
< 1-2-345-6-7-8-9-1
not very strong

Belief # I Rating
Belief #2 Rating
Belief #3 Rating

07
very strong
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8. Compared to others, how unusual is each of your beliefs? (How likely is it
that others have the same belief about themselves that you have about
yourself?)
<1-2-34-5-&7-&9-1
not very strong

Belief #1 Rating
Belief #2 Rating
Belief #3 Rating

O>
very strong

Appendix

H

Items from the Beck Depression Inventory

1. Sadness
0 I do not feel sad
1 I feel sad much of the time
2 1 am sad all the time
3 1 am so sad or unhappy that I can't stand it
2. Pessimism
0 I am not discouraged about my future
1 I feel more discouraged about my future than I used to be
2 1 do not expect things to work out for me
3 1 feel my future is hopeless and will only get worse

3. Past Failure
0 I do not feel like a failure
1 I have failed more than I should have
2 As I look back, I see a lot of failures
3 1 feel I am a total failure as a person
4. Loss of Pleasure
0 I get as much pleasure as I ever did from the things I enjoy
1 I don't enjoy things as much as I used to
2 1 get very little pleasure from the things I used to enjoy
3 1 can't get any pleasure from the things I used to enjoy

5. Guilty Feelings
0 I don't feel particularly guilty
1 I feel guilty over many things I have dome or should have done
2 1 feel quite guilty most of the time
3 1 feel guilty all of the time
6. Punishment Feelings
0 I don't feel I am being punished
1 I feel I may be punished
2 1 expect to be punished
3 1 feel I am being punished
7. Self-Dislike
0 I feel the same about myself as ever
1 I have lost confidence in myself
2 1 am disappointed in myself
3 1 dislike myself

8. Self-criticalness
0 I don't criticize or blame myself more than usual
1 I am more critical of myself than I used to be
2 1 criticize myself for all of my faults
3 1 blame myself for everything bad than happens

9. Suicidal Thoughts or Wishes
0 I don't have any thoughts of killing myself
1 I have thoughts of killing'myself, but I would not carry them out
2 1 would like to kill myself
3 1 would kill myself if I had the chance
10. Crying
0
1
2
3

I don't cry anymore than I used to
I cry more than I used to
1 cry over every little thing
1 feel like crying but I can't

11. Agitation
0 I am no more restless or wound up than usual
1 I feel more restless or wound up than usual
2 1 am so restless or agitated that it's hard to stay still
3 1 am so restless or agitated that 1 have to keep moving or doing
something
12. Loss of Interest
0 I have not lost interest in other people or activities
1 I am less interested in other people or things than before
2 1 have lost most of my interest in other people or things
3 It's hard to get interested in anything
13. Indecisiveness
0 I make decisions about as well as ever
1 I find it more difficult to make decisions than usual
2 1 have much greater difficulty in making decisions than I used to
3 1 have trouble making nay decisions
14. Worthlessness
0 I do not feel I am worthless
1 I don't consider myself as worthwhile and useful as I used to
2 1 feel more worthless as compared to other people
3 1 feel utterly worthless
15. Loss of Energy
0 I have as much energy as ever
1 I have less energy than I used to have
2 1 don't have enough energy to do very much
3 1 don't have enough energy to do anything

16. Changes in Sleeping Pattern
0 I have not experienced any change in my sleeping pattern
1a I sleep somewhat more than usual
1b I sleep somewhat less than usual
2a I sleep a lot more than usual
2b I sleep a lot less than usual
3a I sleep most of the day
3b I wake up 1-2 hours early and can't get back to sleep
17. Irritability
0 I am no more irritable than usual
1 I am more irritable than usual
2 1 am much more irritable than usual
3 1 am irritable all the time
18. Changes in Appetite
0 I have not experienced any change in my appetite
l a My appetite is somewhat less than usual
1b My appetite is somewhat greater than usual
2a My appetite is much less than before
2b My appetite is much greater than before
3a I have no appetite at all
3b I crave food all the time
19. Concentration Difficulty
0 I can concentrate as well as ever
1 I can't concentrate as well as usual
2 It's hard to keep my mind on anything for very long
3 1 fond I can't concentrate on anything
20. Tiredness or Fatigue
0 I am no more tired or fatigued than usual
1 I get more tired or fatigues more easily than usual
2 1 am too tired or fatigued to do a lot of things I used to do
3 1 am too tired or fatigued to do most of things I used to do
21. Loss of Interest in Sex
0 I have not noticed any recent change in my interest in sex
1 I am less interested in sex than I used to be
2 1 am much less interested in sex now
3 1 have lost interest in sex completely

Appendix I
Treatment Conditions
CONDITION 1:
Client #
1

Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy
(1 week)
(4 weeks/
(3 weeks)
(4 weeks1
8 sessions)
8 sessions)

2

Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy
(2 weeks)
(4 weeks/
(2 weeks)
(4 weeks/
8 sessions)
8 sessions)

3

Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy
(3 weeks)
(4 weeks/
(1 week)
(4 wee ksl
8 sessions)
8 sessions)

CONDITION 2:
Client #
4

Baseline --- Cognitive Therapy -- Baseline -- Behavior Therapy
(1 week)
(4 weeks/
(3 weeks)
(4 weeks/
8 sessions)
8 sessions)

5

Baseline -- Cognitive Therapy -- Baseline -- Behavior Therapy
(4 wee ksl
(2 weeks)
(4 weeks/
(2 weeks)
8 sessions)
8 sessions)

6* Baseline -- Cognitive Therapy -- Baseline -- Behavior Therapy
(3 weeks)

* drop-out

(4 weeks/
8 sessions)

(1 week)

(4 weeks1
8 sessions)

Appendix J
Points of Assessment
(Al*) Baseline (A2) Treatment (A3) Baseline (A4) Treatment (A5)

* A = Assessment Time

Appendix K
Subiective Units of Distress Scale
Day:
Date:
ERP exercise: Exposure

: Response Prevention

Ratinq

Appendix L
Cognitive Distortions
1. All-or-None Thinking: You see things in black and white categories.
If your performance falls short of perfect, you see yourself as a total
failure.
Example: "I have a blemish, my whole face is ruined."

2. Overgeneralization: You see is single negative event as a neverending pattern of defeat.
Example: "Heishe doesn't like me, I'll never get a date."
3. Mental Filter: You pick out a single negative detail and dwell on it
exclusively so that your vision of reality is darkened, like a drop of ink that
discolors the entire contained of water.
4. Disqualifying the Positive: You reject positive experiences by
insisting the "don't count" for some reason or another. In this way you
can maintain a negative belief even thought it is contradicted by everyday
experiences.
Example: When someone compliments your appearance, you think, "Oh
he's just trying to be nice." Or "I did well on this test, but it was just luck."

5. Jumping to Conclusions: You make a negative interpretation even
thought there are no definite facts that convincingly support your
conclusion. This includes mind-reading (concluding that someone is
reacting negatively to you without actual evidence) and fortune-telling
(anticipating that things will turn out badly and mistaking your prediction as
fact).
Example: "He didn't say hello. He must think I'm ugly."
Example: "If I ask her out, She'll laugh in my face. I know it."
6. Magnification or Minimization: You exaggerate the importance of
things not done well and minimize the importance of those done well.

7. Emotional Reasoning: You assume that your emotions reflect the
way things really are.
Example: "I feel guilty, so I must have done something wrong."
Example: "I feel sad, my life must be awful."

8. Should Statements: You try to motivate yourself with "shoulds,"
musts," and "oughts." The emotional consequences of not complying with
these self-imposed demands is guilt. When shoulds are directed at
others, anger, frustration, and resentment results.
Example: "I should get up at 5 3 0 am and exercise before work."
Example: "I must lose 10 pounds before the summer."
Example: "I shouldn't have sucha big nose."

9. Labeling: Instead of describing the behavior, you attach a negative
label to yourself or someone else.
Example: "I am a loser."
Example: "That guy is a jerk."

10. Personalization: You incorrectly see yourself as the cause of some
negative event.
Example: "It's my fault that everyone left the party early."
Example: "I ruined the holiday for everyone."

Appendix M
Daily Thought Diarv
Situation:
Describe the actual event leading to the unpleasant emotion.

Emotion:
Specify the emotion and rate the strength of emotion from 1-100.

Automatic Thoushts:
Write the automatic thoughts that preceded the emotion and rate the
degree of belief in those thoughts from 0-100.

Rational Response:
Write rational responses to the irrational automatic thoughts and rate the
degree of belief in the rational statements from 0-100.

Appendix N
Visual Inspection Criteria
The following guidelines outlined by Parsonson and Baer (1978)
were utilized in the visual analysis of the daily data. The first set of
guidelines addresses variability in the data. First, the stability of the
baseline will be inspected. Ideally, in order to draw reasonable
conclusions about the effect of treatment, any trends in the baseline data
should be in the direction opposite to improvement. Second, variability
within treatment phases will be examined, with an optimal pattern being
one of sudden or steady improvement during treatment. Patterns of high
variability within the treatment phase may indicate the influence of external
controlling variables. Third, the variability between baseline and treatment
phases will be inspected, in which experimental control is indicated by
relatively stable treatment phase data that follows variable baseline data.
Experimental control is less evident when both treatment and baseline
phases are variable. Fourth, attention should be paid to the amount of
overlap between baseline and treatment data points. Although there are
no set criteria for an acceptable amount of overlap, the most convincing
treatment effects show less overlap. In addition, overlap of data in the first
few treatment sessions is more acceptable.
The second set of guidelines addresses patterns in the data that
may be indicative of treatment success. First, attention will be paid to any
changes in overall trend within phases. For instance, in the baseline

phase, any trend toward improvement in the final data points may raise
concerns about a natural remission being misconstrued as a positive
treatment effect. Likewise, any deterioration in the final stages of
treatment would raise concerns about loss of control of the treatment
effect. Trends may be determined by drawing a trend line through the
data points: data in the phase are divided into two groups, the mean of
each is calculated and plotted, and a straight line is drawn to connect the
two points. Second, changes in trend, or slope, between baseline and
treatment phases will be inspected, in which strong indications of
treatment effects are evidenced by a lack of baseline trend followed by
downward trend during treatment. Baseline trends toward improvement
that increase during treatment suggest that the trend would have
continued in the absence of therapy. Third, changes in level between
phases will be examined, in which greater and more abrupt changes in
level are more indicative of treatment effectiveness.

Appendix 0
Clinical Siqnificance
Commonly thought of as a return to normal functioning, clinical
significance refers to the meaningfulness of change in the client's daily
life, and is a necessary component of treatment research (Jacobson,
Roberts, Berns, & McGlinchey, 1999; Kendall, 1997). In order for a
treatment to be meaningful, it must create a practical and noticeable
improvement in the daily life of the client or in the lives of significant others
(Kazdin, 1999; Kendall & Norton-Ford, 1982). The assessment of clinical
significance is not meant to replace a statistical evaluation. However,
following support that results are not due to chance, the demonstration of
clinical meaningfulness is necessary (Chambless & Hollon, 1998; Kendall,
1999).
Several methods of assessing clinical significance have been
proposed in recent years. The reliability change index (RCI) statistically
assesses whether the degree of change on a questionnaire measure is
due to chance (Jacobson et al., 1999; Jacobson & Truax, 1991). In order
to determine whether the amount of change exceeds the margin of
measurement error, the RCI is calculated by dividing the magnitude of
therapeutic change by the standard error of the difference score
(Jacobson et al., 1999). Then, in order to determine clinical significance,
the RCI is used in tandem with useful cutoff points. Jacobson and Truax
(1991) have suggested three mathematical cutoff points that distinguish
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functional from nonfunctional clients. Clinically meaningful improvement
may be demonstrated when the level of functioning (a) falls two standard
deviations outside the range of the dysfunctional population, (b) falls two
standard deviations within the range of the normal population, or (c) is
statistically more likely to fall in the normal than the dysfunctional range.
The difficulty with this method concerns the need of norms and variances
for clinical and nonclinical populations, which are not always available.
However, the benefit to the RCI and cutoff combination is the inclusion of
statistical, objective calculation in the determination of clinical significance.
Clinical significance also may be assessed by statistically
comparing the treatment group to a normal group, with the goal of treated
individuals being indistinguishable from the normative sample on the
relevant measures (Kendall, Marrs-Garcia, Nath, & Sheldrick, 1999).
Other methods of assessing meaningful change include determining the
social validity of improvement (Foster & Mash, 1999; Kazdin, 1977; Wolf,
1978) and whether the change in symptoms improves quality of life
(Gladis, Gosch, Dishuk, & Crits-Christof, 1999). With these methods,
assessment largely depends on self-report of factors such as
interpersonal functioning, quality of work, or leisure activities. However,
the subjective experience of improved quality of life is a valuable outcome
and, therefore, could be an indicator of clinical significance.
The current study assessed clinical significance through two
approaches. In keeping with past BDD outcome research (Geremia,
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1997; Neziroglu et al., 1996; Rosen et al., 1995), one criteria for clinically
significant improvement required the absence of diagnostic criteria for
BDD as assessed by scores on the BDDE. Secondly, clinically
meaningful change on questionnaire measures was assessed using the
statistical approach to clinical significance (Jacobson and Truax, 1991).
This method was chosen due to its objective ability to determine
meaningful improvement. Of the three suggested mathematical cutoff
points described above, two standard deviations below the clinical mean
was chosen due to the availability of clinical norms and unavailability of
norms for normal populations on many of the measures.
Using BDDE Scores To Assess Clinical Significance
Participants were considered to have met criteria for clinically significant
improvement once they no longer met criteria for BDD. The BDDE (Rosen &
Reiter, 1994) is a semi-structured interview designed to aid in the diagnosis of
BDD. To meet criteria for BDD using the BDDE, individuals must obtain
particular scores on items indicating symptom intensity in the moderately severe
to severe range. In keeping with other BDD treatment studies (Geremia, 1997;
Neziroglu et al., 1996; Rosen et al., 1995), a diagnosis of BDD was considered
absent once these item scores no longer met the prescribed cutoff.
Statistical Approach To Clinical Significance
Clinically significant improvements on questionnaire measures
were assessed using the statistical approach discussed above (Jacobson
& Truax, 1991). First, the reliability change index (RCI) was calculated to

determine whether the amount of change exceeded the margin of
measurement error. For each measure, four RCl's were calculated by
dividing the magnitude of change from pre- to post-treatment by the
standard error of the difference score. These four RCl's were computed
for each participant by using four different post-treatment points as a
measure of improvement over time. In other words, post-Treatment 1,
pre-Treatment 2, post-Treatment 2, and Follow-up scores, respectively,
were subtracted from pre-baseline scores to form the numerator. The
denominator (i.e., standard error of the difference score) was calculated
by obtaining the square root of the standard error squared multiplied by
two. In turn, the standard error of measurement was calculated by
obtaining the square root of one minus the test-retest reliability of the
questionnaire. Then, in order for post-treatment improvement to be
considered beyond the reliability of the measure, the value of the RCI
must exceed the standard error of measurement for that questionnaire.
Table 11 presents the values used in determining the RCl's for each
measure, and Table 12 through Table 16 presents the RCI values for each
measure.

Table 0.1.
Scores Required in the Calculation of Clinical Siqnificance for All Questionnaire
Measures.

I
I

1

sd

YBOCSBDD
7.5

1

I

AS I

I

OVlS

I

SADS

I

BDI-II

.67

2.4

8.01

11.74

r-xx

.88

.71

.93

.68

.93

SE

2.59

.36

.63

4.53

3.12

s-d iff

3.66

-51

.89

6.41

4.41

clinical
mean
cutoff score

29.3

2.61

5.7

9.1 1

29.45

14.3

1.27

-90

--

6

Table 0.2.
YBOCS-BDD Reliabilitv Chanqe Index Scores for All Clients.
PreTreatment 2
-.27

PostTreatment 2
-1.09

Follow-up

Client 1

PostTreatment 1
-1.09

Client 2

-3.27++

-2.73++

-2.73++

-3.27++

Client 3

-4.64++

-3.55++

-2.45

-2.45

Client 4

1.37

.82

.27

.55

Client 5

-2.46

-2.19

-3.55++

-3.83++

-.82

+ RCI value greater than standard error of measurement
++ RCI value greater than standard error of measurement and meets criteria for
2 standard deviations below clinical mean

Table 0.3.
AS1 Reliabilitv Chanqe lndex Scores for All Clients.

I

Client 1

PostTreatment 1
-.71+

PreTreatment 2
0.00

PostTreatment 2
0.00

Client 2

-.84+

.55+

-1.27+

-1.41+

Client 3

-.96+

-.55+

-1.39+

-1.lo+

Client 4

-1.80+

-.41+

-.41+

-.82+

I

I

I

-.71+

Client 5

Follow-up

.55+

I

-.98+

-.84+

-.29+

+ RCI value greater than standard error of measurement
++ RCI value greater than standard error of measurement and meets criteria for
2 standard deviations below clinical mean

Table 0.4.
OVlS Reliabilitv Chanqe lndex Scores for All Clients.

I

I

I

PreTreatment 2
-1.40+

I

postTreatment 2
.42

I

Client 1

postTreatment 1
-.98+

FOHOW-up

Client 2

.28

-.2 1

.28

-.56

Client 3

-1.83+

-2.1 I +

-1.27+

-.99+

Client 4

-1.12+

.I5

-.67+

.43

Client 5

-2.96+

-2.58+

-5.95+

-2.25+

-1.40+

+ RCI value greater than standard error of measurement
++ RCI value greater than standard error of measurement and meets criteria for
2 standard deviations below clinical mean

Table 0.5.
SADS Reliability Change lndex Scores for All Clients.

I

Client 1

PostTreatment 1
.31

PreTreatment 2
-.I6

PostTreatment 2
-.47

Client 2

-.47

-.I6

-1.09

-1.72

Client 3

-1.25

-1.40

-1.09

-1.72

Client 4

0.00

.I
6

.I6

-16

Client 5

0.00

0.00

-2.1 8

-2.50

Follow-up
-.I6

+ RCI value greater than standard error of measurement
++ RCI value greater than standard error of measurement and,meets criteria for
2 standard deviations below clinical mean

Table 0.6.
BDI-II Reliability Chanqe lndex Scores for All Clients.
PreTreatment 2
.68

PostTreatment 2
.9 1

Follow-up

Client 1

PostTreatment 1
2.72

Client 2

-1.36

-15 9

-3.85++

-3.63++

Client 3

-1.81

-1.36

-1.36

-2.95

Client 4

-.68

.68

0.00

-1.81

Client 5

-1.36

-1.36

-3.85++

-2.94

4.76

+ RCI value greater than standard error of measurement
++ RCI value greater than standard error of measurement and meets criteria for
2 standard deviations below clinical mean

Secondly, for those comparisons yielding appropriate RCl's, the
criteria for clinically significant improvement was assessed. Thus, the
post-treatment scores resulting in a sufficient RCI values were examined
to determine whether that score was equal to or less than two standard
deviations below the clinical population mean (Jacobson & Truax, 1991).
Published means, standard deviations, and cutoff scores for the outcome
measures are presented in Table 11 (YBOCS: Phillips et al., 1997; ASI:
Cash & Labarge, 1996; OVIS: Neziroglu et al., 1998; SADS: Watson &
Friend,1969; BDI-II: Beck et al, 1996).

Appendix P
Summarv of Clients
Client 1
Client 1 was a 39 year-old female with a Masters degree in the
social sciences. She lived with her daughter and partner, and had several
past therapy experiences for depression. She experienced intense
preoccupation with the beliefs that her stomach and thighs were extremely
large, and that her face and body appeared old. The distress generated
from appearance-related thoughts led to excessive mirror-checking,
weighing, assessing size through touching, reassurance-seeking, and
comparing herself to the appearance of other young women in person and
in magazines, television, and other media sources. At the beginning of
therapy she avoided many social situations and continually dressed in
baggy clothing designed to camouflage her stomach and thighs. She also
reported feeling high levels of depression and continually experienced
thoughts such as "I am repulsive," "Not only do I not look pretty but I look
like I belong to another species," "The way I look is so humiliating," and "I
am ugly and worthless."
Following the study, she reported that she was able to gain periods of
insight into her appearance beliefs and sometimes was able to challenge her
negative thoughts. She stated "I have changed from being all-consumed by my
thoughts to being able to attack them. I feel like [the thoughts] are external to me
and under my control."

Client 2
Client 2 was a 41 year-old male with a Bachelor's degree in the social
sciences. At the time of the study, he lived with his parents and was unemployed
due to extreme concern about his appearance. Past therapy experiences
included a cognitive-behavioral group for social phobia, and he currently was
taking an SSRl for chronic depression. Client 2 spent hours each day worrying
about the configuration of his lips, which he described as ugly and weird. He
firmly believed that the corners of his mouth turned down dramatically and that
others would perceive him as ridiculous and ugly. Interestingly, during his early
adolescence, he had worn an external mouth brace and was teased often by
peers. In addition, he changed schools several times throughout his childhood
and adolescence due to his father's many jobs, and experienced difficulty with
teasing each time. At the time of the study, he experienced intense distress in
public and social situations, however he forced himself to leave the house,
believing that isolation would be detrimental to his emotional health. While in
public, he would constantly engage in behaviors designed to hide his lips or to
distract others' attention from them (e.g., turning his head, walking sideways,
hiding behind trees or other large objects, covering mouth with hand, eating,
taking continuous sips of a drink, talking incessantly to avoid stillness of lips). In
addition, he experienced thoughts such as "I am so ugly," "I shouldn't expose
others to this deformity," everyone is looking at me and thinking I am ugly," and "I
am inferior and inadequate."
Following the study, he stated that his depression had lifted for the

first time in years. In addition, he had gained excellent insight into his
appearance, stating that the real problem was not actually with his lips but
with his feelings of inferiority. He reported enjoying social situations again,
and that he felt hopeful about the future.
Client 3
Client 3 was a 21 year-old male with a high school education. At
the time of the study he was unemployed and had discontinued postsecondary education due to appearance-related concerns and depression.
In addition, he lived with his parents following a recent divorce, and stated
that his wife had left him because he spent too much time obsessing over
his appearance and asking for reassurance. He reported experiencing
appearance-related concerns for as long as he could remember, and was
hospitalized twice in adolescence for suicide attempts related to
appearance concerns. He had been taking a stable dose of an SSRl for
several years.
At the time of the study, Client 3 believed that his face was covered with
pimples, which caused him to appear disgusting and ugly. Due to intense
distress, he grew a beard to hide the pimples and avoided most public and social
situations, spending his days sleeping or watching television in his bedroom. He
refused to leave his bedroom without applying concealing makeup and, if forced
to appear in public, would go to great lengths to avoid being seen (e-g., crossing
the street, hiding behind objects, walking in the opposite direction). Additional
hours were spent checking his complexion in the mirror and picking at perceived
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pimples. Following treatment, he reported good insight and a notable decrease
in depression and overall distress. In addition, he shaved his beard, enrolled in
college classes, and asked a woman out on a date.
Client 4
Client 4 was a 44 year-old female with some post-secondary education.
She reported a varied employment history including secretarial work, homecare,
and driving 18-wheelers across the country. At the time of the study, she lived
with her husband and young daughter, and was unemployed due to appearancerelated concerns and incapacitating symptoms related to anxiety and depression.
Her home environment was extremely stressful. During the course of the study,
she had her husband arrested for assault and interrupted her older daughter
attempting to commit suicide. In addition, she was coping with distress related to
her own severe childhood abuse perpetrated by her mother. Her distress level
was so high that the first five minutes of session typically involved her trembling
and pacing back and forth in the therapy room in an effort to calm herself enough
to sit down.
At the time of the study, she reported being extremely distressed with the
appearance of her face, which she described as repulsive and hideous. In
particular, she believed that it was not "put together correctly" and that she had
no right to ever expose others to such a shockingly disgusting sight. Leaving her
house only to come to session, she wore large sunglasses and a hat pulled down
over her face. She chose small back roads to drive to session, in order to reduce
the number of people who might see her face as they drove in the opposite
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direction. In addition to the avoidance of public situations, she engaged in hours
of mirror-checking each day. With regard to negative self-statements, she
frequently had thoughts such as "I am disgusting inside and out," "I am
unlovable," "People would vomit if they really saw my face." Following
completion of the study, Client 4 did not report any decrease in symptoms and
was referred for longer-term treatment.
Client 5
Client 5 was a 32 year-old female with a high school education.
She lived with her husband and was unemployed due to chronic physical
health difficulties. Appearance-related concerns had developed over the
past several years, although she recalled always being a socially awkward
child. She described herself as a "tomboy" in childhood and indicated that
her mother, whom she described as controlling and manipulative, had
frequently reprimanded her for not acting sufficiently feminine. Past
therapy experiences included one course of supportive psychotherapy for
depression, an assertiveness training course, and an SSRl for
depression.
At the time of the study, Client 5 firmly believed that her torso and
arms were excessively muscular and that she "looked like a boy."
Although she was approximately five feet and four inches tall with a small
frame, she reported being extremely embarrassed by her bulky, "wrestlerlike" appearance. Negative thoughts about her body (e.g., "I look like a
freak," "I have no right to subject others to this abnormality," "how can [my

husband] stand to look at me?") led to intense feelings of depression,
hopelessness, and inadequacy. In turn, she seldom left the house, even
to check the mailbox, and dressed in very baggy clothing in order to
camouflage her muscles from her husband. If her husband's friend
dropped by to visit, she would run to the bathroom and stay there until the
visitor had left. Following treatment, she stated that she wore more formfitting clothing around her house and that the improved insight regarding
appearance had led to a higher quality relationship with her husband and
greater self-confidence. During the last session, she stated "Some days I
did not want to be. Now life is good."
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